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Abstract
γ-aminobutyric acid (GABA) is the main inhibitory transmitter in the nervous system and 
acts  via  three  distinct  receptor  classes:  A,  B,  and C.  GABAC receptors  are  ionotropic 
receptors comprising ρ subunits. In this work, we aimed to elucidate the expression of ρ 
subunits in the postnatal brain, the characteristics of ρ2 homo-oligomeric receptors, and the 
function of GABAC receptors in the hippocampus.
In  situ hybridization  on  rat  brain  slices  showed  ρ2 mRNA expression  from the 
newborn in the superficial grey layer of the superior colliculus, from the first postnatal 
week in the hippocampal CA1 region and the pretectal nucleus of the optic tract, and in 
the adult dorsal lateral geniculate nucleus. Quantitative RT-PCR revealed expression of all 
three ρ subunits in the hippocampus and superior colliculus from the first postnatal day. In 
the hippocampus, ρ2 mRNA expression clearly dominated over ρ1 and ρ3. GABAC receptor 
protein  expression  was  confirmed  in  the  adult  hippocampus,  superior  colliculus,  and 
dorsal lateral geniculate nucleus by immunohistochemistry. From the selective distribution 
of  ρ  subunits,  GABAC receptors  may  be  hypothesized  to  be  specifically  involved  in 
aspects of visual image motion processing in the rat brain.
Although previous data had indicated a much higher expression level for ρ2 subunit 
transcripts than for ρ1 or ρ3 in the brain, previous work done on  Xenopus oocytes had 
suggested that rat ρ2 subunits do not form functional homo-oligomeric GABAC receptors 
but need ρ1 or ρ3 subunits to form hetero-oligomers. Our results demonstrated, for the first 
time, that HEK 293 cells transfected with ρ2 cDNA displayed currents in whole-cell patch-
clamp recordings. Homomeric rat ρ2 receptors had a decreased sensitivity to, but a high 
affinity for picrotoxin and a marked sensitivity to the GABAC receptor agonist CACA. 
Our results suggest that ρ2 subunits may contribute to brain function, also in areas not 
expressing other ρ subunits.
Using extracellular electrophysiological recordings, we aimed to study the effects of 
the GABAC receptor agonists and antagonists on responses of the hippocampal neurons to 
electrical  stimulation.  Activation  of  GABAC receptors  with  CACA  suppressed 
postsynaptic excitability and the GABAC receptor antagonist TPMPA inhibited the effects 
of  CACA.  Next,  we  aimed  to  display  the  activation  of  the  GABAC receptors  by 
synaptically released GABA using intracellular recordings. GABA-mediated long-lasting 
depolarizing responses evoked by high-frequency stimulation were prolonged by TPMPA. 
For  weaker  stimulation,  the effect  of  TPMPA was enhanced after  GABA uptake was 
inhibited. Our data demonstrate that GABAC receptors can be activated by endogenous 
synaptic transmitter release following strong stimulation or under conditions of reduced 
GABA uptake. The lack of GABAC receptor activation by less intensive stimulation under 
control  conditions  suggests  that  these  receptors  are  extrasynaptic  and  activated  via 
spillover of synaptically released GABA.
Taken together with the restricted expression pattern of GABAC receptors  in the 
brain  and  their  distinctive  pharmacological  and  biophysical  properties,  our  findings 
supporting extrasynaptic localization of these receptors raise interesting possibilities for 
novel  pharmacological  therapies  in  the  treatment  of,  for  example,  epilepsy  and  sleep 
disorders.
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Abbreviations
The long pharmacological names of the compounds mentioned in the text are given only 
in this list, while all other abbreviations are explained the first time they appear.
2-MeTACA 2-trans-4-amino-2-methylbut-2-enoic acid
3-APA 3-aminopropylphosphinic acid
3-APMPA 3-aminopropyl(methyl)-phosphinic acid
3-APS 3-aminopropanesulphonic acid
5α-THDOC allotetrahydrodedoxycorticosterone
5β-THDOC tetrahydrodedoxycorticosterone
5-HT3 5-hydroxytryptamine (or serotonin) receptor type 3
ACSF artificial cerebrospinal fluid
AP5 D-2-amino-5-phosphonopentoate
ATP adenosine trisphosphate
BIM bicuculline methiodide
CA1, CA3, CA4 cornu ammonis 1, 3, and 4
CACA cis-4-amino crotonic acid
(±)-CAMP (±)-cis-2-(aminomethyl)cyclopropanecarboxylic acid
cDNA complementary deoxyribonucleic acid
CGP 36742 (3-aminopropyl-n-butyl)phosphinic acid
CGP 46381 (3-aminopropyl)(cyclohexylmethyl)phosphinic acid
CNQX 6-cyano-7-nitroquinoxaline-2,3-dione
dLGN dorsal lateral geniculate nucleus
DRG dorsal root ganglia
DVN dorsal vagal nucleus
EC50 half-maximal effective agonist concentration
ECl reversal potential for chloride
EEG electroencephalography
EMG electromyography
ERG electroretinogram
GABA γ-aminobutyric acid
GAT-1,  GAT-3 GABA transporter-1 and -3
GDNSP GABA-mediated depolarizing non-synaptic potential
GDPSP GABA-mediated depolarizing postsynaptic potential
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GLYT-1E/F glycine transporter (C-terminal) splice variant
HEK 293 human embryonic kidney cell line
HFS high-frequency stimulation
hIPSP hyperpolarizing inhibitory postsynaptic potential
I4AA imidazole-4-acetic acid
IC50 half-maximal effective antagonist concentration
INL inner nuclear layer
Kb estimated binding constant of the antagonist
KCC2 potassium-chloride co-transporter
LTP long-term potentiation
MAP1B microtubule-associated protein 1B
mRNA messenger ribonucleic acid
MTN median terminal nucleus of the accessory optic tract
NKCC1 sodium-potassium-chloride co-transporter
NOT pretectal nucleus of the optic tract
P postnatal day
P4MPA (piperidine-4-yl)methylphosphinic acid
P-4-S piperidine-4-sulphonic acid
pEPSP population excitatory postsynaptic potential
PiTX picrotoxin
PKC protein kinase C
pSpike population spike
qRT-PCR quantitative reverse-transcriptase polymerase chain reaction
REM rapid eye movement
SGL superficial grey layer
SKF 89976A N-(4,4,-diphenyl-3-butenyl)-3-piperidinecarboxylic acid
SR95531 2-(3-carboxypropyl)-3-amino-6-(p-methoxyphenyl)pyridazinium 
bromide or gabazine
STC-1 gut neuroendocrine tumour cell line
SuC superior colliculus
TACA trans-4-amino crotonic acid
TAMP trans-2-(aminomethyl)cyclopropanecarboxylic acid
TBPS t-butylbicyclophosphorothionate
THIP 4,5,6,7,-tetrahydroisoxazolo{5,4-c}pyridin-3-ol or gaboxadol
TPMPA (1,2,5,6-tetrahydropyridin-4-yl)methylphosphinic acid
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1. Introduction
γ-aminobutyric  acid (GABA) is  the main inhibitory transmitter  in the nervous system. 
GABA acts via three distinct receptor classes: A, B, and C. GABAA and GABAC receptors 
are ionotropic receptors, i.e. they are ligand-gated ion channels (Fig. 1). The vast group of 
ligand-gated ion channels is divided into three superfamilies: the nicotinicoid superfamily, 
the  excitatory  glutamate  receptors,  and  ATP  receptors.  The  nicotinicoid  superfamily 
encompasses several families of receptors, including nicotinic acetylcholine receptors, 5-
HT3 receptors,  GABAA receptors,  GABAC receptors,  strychnine-sensitive  glycine 
receptors,  and  some  invertebrate  anionic  glutamate  receptors.  All  members  of  the 
superfamily are considered to be pentamers.
                GABAA receptor               GABAB receptor                  GABAC receptor
Fig. 1. GABA receptor classes.
GABAA receptors  are  heteropentameric  ionotropic  receptors,  GABAB receptors  are 
heterodimeric metabotropic receptors coupled to second messenger systems and GABAC 
receptors are homo- or heteropentameric ionotropic receptors.
Each GABAA or GABAC receptor subunit consists of four transmembrane domains, 
a  long N-terminal  extracellular  domain with a cysteine loop, and an intracellular  loop 
between the third and fourth transmembrane domains. The second transmembrane part 
lines the integral anion channel and has the highest proportion of conserved amino acids of 
all ionotropic GABA receptors. Binding sites for GABA and other ligands as well as for 
antagonists,  picrotoxin  block,  and  oligomerization  signals  have  all  been  connected  to 
particular areas of interest on the structure of the receptor, either in the transmembrane 
region or in the N-terminal domain (reviewed by Chebib and Johnston, 2000).
GABAB receptors  are  metabotropic,  i.e.  they act  via  a  G-protein-coupled second 
messenger system, and their activation regulates inwardly rectifying potassium channels 
on the cell membrane. GABAB receptors can also function as presynaptic autoreceptors, 
reducing calcium current, and subsequently, transmitter release at the nerve terminal. They 
are slower  than ionotropic  receptors  and usually  modulate  the response of  the neuron 
rather  than participating in the fast  messaging between pre- and postsynaptic  neurons, 
which  is  classically  taken  as  the  task  for  fast-acting  ionotropic  receptors.  GABAB 
receptors are considered to be heterodimers consisting of GABAB1 and GABAB2 subunits 
(reviewed by Cryan and Kaupmann, 2005). 
GABAC receptors are pharmacologically defined by their insensitivity to GABAA 
receptor  antagonist  bicuculline  and  to  GABAB receptor  agonist  baclofen.  The  first 
evidence  for  the  existence  of  GABAC receptors  came  in  1975  from  cat  spinal  cord 
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interneurons,  where bicuculline-insensitive,  CACA-sensitive responses were discovered 
(Johnston  et al., 1975). In 1984, CACA-sensitive responses were shown to be baclofen-
insensitive in the rat cerebellum (Drew et al., 1984). Gradually, these and other findings 
led to the idea of a third subclass of GABA receptors, termed GABAC receptors (Drew et  
al., 1984). As the first subunit of these new receptors was cloned from a retinal cDNA 
library, they were named ρ after retina (Cutting  et al., 1991). The nomenclature is still 
under debate, however, and will be further discussed at the end of this thesis.
More than a decade of intensive studies concerning ρ subunits and GABAC receptors 
had revealed a great deal of information, especially on their molecular structure, but less 
on their function and very little on their role outside the retina and superior colliculus. The 
aim of this study was to elucidate the expression and characteristics of functional GABAC 
receptors in the brain both during development and with particular emphasis on the adult 
hippocampus, the centre for learning and memory, with established neuronal networks.
10
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2. Review of the Literature
2.1. GABAA receptors
The classical picture of GABAA receptors is of postsynaptic receptors rapidly activating, 
deactivating, and desensitizing. Prototypic GABAA receptors are known to be inhibited 
competitively  by  bicuculline  and  non-competitively  by  picrotoxin  and  potentiated  by 
benzodiazepines, barbiturates, ethanol, and neuroactive steroids (reviewed by MacDonald 
and Olsen,  1994).  Still,  in  different  brain  cells  and regions,  there  is  a  vast  variety  of 
different GABAA receptor subtypes with distinct characteristics depending on the subunits 
involved. Johnston (1996a) has described GABAA receptors as the most complicated of 
the superfamily of ligand-gated ion channels in terms of the large number of receptor 
subtypes and the variety of ligands that interact with specific sites on the receptors.
2.1.1. GABAA receptor subunits
To date, 16 GABAA receptor subunit genes have been characterized: α1–6, β1–3, γ1–3, δ, ε, θ, 
and π (Barnard et al., 1998; Bonnert et al., 1999; Sinkkonen et al., 2000). The variety is 
further extended by several splice variants, among which the short and long isoforms of γ2 
are perhaps the most studied (Whiting et al., 1990). Yet, the two most abundant GABAA 
receptor subtypes in the adult brain are supposed to consist of either two α1, two β2, and 
one γ2 subunit, or one α2, one α3, two β3, and one γ2 subunit (McKernan and Whiting, 
1996).  Although  many  GABAA receptor  subunits  can  inefficiently  assemble  to  form 
homo-oligomeric receptors, when transfected alone in heterologous expression systems, 
these  receptors  have  small  currents  and  distorted  pharmacology,  and  native  GABAA 
receptors seem to always need α and β subunits for functionality. Extensive studies with 
recombinant receptors and genetically engineered mice have shed some light on the role of 
various subunits (reviewed by Korpi et al., 2002 and Vicini and Ortinski, 2004).
Of the six distinct α subunits, α1, α2, and α3 are thought to be localized at synapses, 
while α4, α5, and α6 dominate the sites outside the synapse and have a higher sensitivity to 
GABA than their synaptic counterparts. α1 and α4 subunits produce fast current decay, α2 
and α3 prolong current deactivation (i.e. returning to the baseline current level after an 
agonist has left the receptor), α5 subunit currents desensitize less, while α6 subunit currents 
deactivate very slowly and lack desensitization (i.e. they stay open even with a very long 
agonist  application).  Naturally, all  of these properties are also strongly affected by the 
presence of γ or δ subunits. Extrasynaptic receptors will be discussed in more detail in 
Section 2.1.2.  α1  subunit-containing receptors characteristically  possess  high affinity to 
benzodiazepines, but these drugs seem to have subtype-specific effects on other α subunits 
as well. Receptors with various α subunits have been differentially connected to memory, 
sedation, anxiety, and cortical plasticity (reviewed by Rudolph and Möhler, 2006).
Of the three β subunits, β3 (preferentially assembled with α2/3) seems to be crucial in 
the developing brain,  and β3 knock-out mice have a short life span and severe loss of 
GABA  receptors  together  with  functional  deficits,  resembling  some  features  of 
11
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Angelman's syndrome, a human neurodevelopmental disorder. β subunits are involved in 
the  action  of  anaesthetics,  β2 subunit-containing  receptors  mediating  sedation  and  β3 
receptors anaesthetic immobility in mouse models (Siegwart  et al.,  2003; Zeller  et al., 
2007).
γ subunits, on the other hand, carry the signals for targeting and clustering GABAA 
receptors  at  synapses  as  well  as  for  forming  the  binding  site  for  benzodiazepines, 
mediating their allosteric action on the adjacent GABA binding sites, and thus, generating 
benzodiazepine sensitivity. While mice lacking the γ2 subunit die young, heterozygous γ2 
mice have reduced GABAA receptor clustering, benzodiazepine binding, and an anxious 
phenotype.  The δ  subunit  is  abundantly  expressed  outside  synaptic  clefts  and will  be 
discussed further below. To date, not much is known about the role of ε, θ, and π subunits, 
with the last subunit perhaps only expressed in peripheral tissues (reviewed by Korpi  et  
al., 2002 and Vicini and Ortinski, 2004).
2.1.2. Extrasynaptic GABAA receptors
The  classical  type  of  GABAergic  transmission  appears  in  a  way  that,  following 
depolarization  of  the  presynaptic  terminal,  GABA is  briefly  released  from transmitter 
vesicles  and binds to  postsynaptic  GABAA receptors.  Intriguingly,  quantitative  studies 
have  revealed  that,  even  in  the  case  of  a  highly  synapse-enriched  GABAA receptor 
subtype, more receptors are found outside than inside synaptic junctions (Nusser  et al., 
1995). No GABAA receptor subtype has yet  been found to have an exclusive synaptic 
location, but δ subunit-containing receptors were shown to be present only at extra- and 
perisynaptic locations (Nusser et al., 1998; Wei et al., 2003). The δ subunit seems to form 
these purely extrasynaptic receptors specifically with the α6 subunit in cerebellar granule 
cells and with the α4 subunit in the dentate gyrus, thalamus, and neostriatum (Barnard et  
al.,  1998).  Recently,  this  specific  subunit  partnership  has  been  challenged  by  results 
showing the δ subunit together with the α1 subunit at least in hippocampal interneurons, in 
which  these  subunits  seem  to  produce  extrasynaptic  receptors  (Glykys  et  al.,  2007). 
Another  known,  predominantly  extrasynaptic  GABAA receptor  subtype,  present  in 
hippocampal pyramidal cells and interneurons, is formed by α5 and γ2 subunits, despite the 
latter commonly promoting synaptic localization (Crestani  et al., 2002; Semyanov et al., 
2003).
GABAA receptors containing α4 or α6 subunits have an EC50 for GABA of around 0.1 
– 0.7  μM, which is an order of magnitude lower than the EC50 of the most abundant, 
“classical” GABAA receptor subtypes and even a bit lower than that of GABAC receptors 
(Farrant and Nusser, 2005). However, the apparent affinities of native GABAA receptors 
remain unknown, since in certain experimental situations, GABA sensitivities are much 
greater than those found in recombinant experiments (Lindquist and Birnir, 2006). Yet, 
GABA  has  a  low  efficacy  for  δ  subunit-containing  receptors,  i.e.  it  gates  these  ion 
channels  less  efficiently,  leading  to  slow  and  minimal  desensitization  (Bianchi  and 
Macdonald, 2003). Extrasynaptic receptors are insensitive to zolpidem, and all but α5γ2 
receptors also to diazepam, but sensitive to some inhalation anaesthetics  (Barnard et al., 
1998).  In  addition,  the  δ  subunit  is  speculated  to  carry  high  affinity  for  ethanol  and 
neurosteroids (Sundstrom-Poromaa  et al., 2002; Bianchi and Macdonald, 2003; Stell  et  
al.,  2003).  Moreover,  α6 subunit-containing  receptors  are  specifically  antagonized  by 
12
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furosemide (Korpi  et al., 1995), while THIP is a superagonist on α4 subunit-containing 
receptors (Krogsgaard-Larsen et al., 2004).
The properties of extrasynaptic  receptors are perfectly suited to their function in 
tonic  inhibition.  As  opposed  to  fast-acting,  phasic  inhibition  mediated  by  synaptic 
receptors, extrasynaptic receptors are activated on slower time scales by the spillover of 
the transmitter from synapses on the neighbouring cells or by the ambient extracellular 
GABA concentration maintained by GABA transporters and non-synaptic release from 
glia  (Rossi  et  al.,  2003).  In  addition  to  constant  currents,  transmitter  spillage  to 
extrasynaptic  areas  can  also  underlie  slow-rising  GABAergic  inhibitory  postsynaptic 
currents. The single-channel conductance of GABAA receptors mediating a tonic current 
in hippocampal neurons was estimated to be 6 pS, which is significantly lower than that of 
hippocampal GABAA receptors mediating phasic inhibition (Bai  et al., 2001). To date, 
tonic currents mediated by extrasynaptic GABAA receptors have been found in cerebellar 
granule  cells  (Hamann  et  al.,  2002),  hippocampal  interneurons  and  pyramidal  cells 
(Semyanov et al., 2003; Yeung et al., 2003; Caraiscos et al., 2004), dentate gyrus granule 
cells (Nusser and Mody, 2002; Wei et al., 2003), and thalamic relay neurons (Porcello et  
al., 2003). 
The role of the tonic inhibition is not yet thoroughly established, but several theories 
have been tendered. In the cerebellum, tonic inhibition alters the gain of transmission of 
the  network,  potentially  improving  the  information  storage  capacity  (Hamann  et  al., 
2002).  In  hippocampal  interneurons,  tonically  active  GABA  receptors  regulate  the 
excitability, and thus, the extent of network oscillations, which are crucial for distributed 
signal processing (Semyanov  et al.,  2003; 2004). In the hippocampus, adult  pyramidal 
cells, in contrast to interneurons, possess apparent tonic currents only if GABA uptake is 
blocked.  This  is  in  line  with  the  contribution  of  GABA  uptake  to  the  extrasynaptic 
transmitter  concentrations  being  more  important  than  diffusion,  as  in  the  stratum 
pyramidale there are abundant synapses releasing transmitters and a limited volume of 
extracellular space, whereas in the strata radiatum and oriens the extracellular volume is 
relatively  large  and  more  prone  to  diffusion  (Semyanov  et  al.,  2004).  It  has  been 
demonstrated that, where available, tonic inhibition carries larger overall inhibitory charge 
transfer than phasic inhibition, even with frequent synaptic events (reviewed by Farrant 
and Nusser, 2005).
2.2. GABAC receptors
2.2.1. Biophysical properties
GABAC receptors  are  about  10-fold  more  sensitive  to  GABA  than  classical  GABAA 
receptors and their Hill slopes are steeper, reflecting the presence of more ligand binding 
sites on GABAC receptors and more cooperative binding. GABAC receptor currents are 
smaller and they activate and deactivate more slowly. GABAC receptors do not desensitize 
even with  long agonist  applications.  They are  permeable  to  chloride  and bicarbonate, 
similar to GABAA receptors, and their pore size is approximately the same (Feigenspan et  
13
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al.,  1993;  Kusama  et  al.,  1993a;  Qian  and Dowling,  1993;  Feigenspan and Bormann, 
1994; Wang et al., 1994; Johnston, 1996b).
At the single-channel  level,  GABAC receptors  are  characterized by 6-fold longer 
mean open times than GABAA receptors  (Feigenspan  et al.,  1993). The single-channel 
conductance of native GABAC receptors in rat retinal bipolar cells was 7 pS, whereas that 
of GABAA receptors in the same area was 27 pS (Feigenspan et al., 1993; Feigenspan and 
Bormann,  1994).  In  goldfish retinal  bipolar  cells,  the  smaller  conductance  of  GABAC 
receptors  compared  with  GABAA receptors  appeared  to  be  compensated  by  a  greater 
number  of  activated  receptors  per  synapse  (Palmer,  2006).  The  single-channel 
conductance of native GABAC receptors in white perch retina was only 1.36 pS, which lies 
between the values derived for homomeric ρ1 and ρ2 receptors (Zhu et al., 2007).
2.2.2. Pharmacology
GABAC receptors  are  defined  by  their  insensitivity  to  GABAA  receptor  antagonist 
bicuculline  and  to  GABAB receptor  agonist  baclofen.  The  main  pharmacological 
characteristics  of  GABA  receptor  classes  are  summarized  in  Table  1  (reviewed  by 
Johnston, 1996b and Bormann, 2000).
Table 1. Essential pharmacology of GABA receptor classes.
Agonist/
antagonist
GABAA receptors GABAB receptors GABAC receptors
GABA EC50 = 0.1 – 30 μM EC50 = 1.6 – 2.4 μM1 EC50 = 0.8 – 7 μM
Muscimol Potent agonist Inactive Partial agonist
TACA Potent agonist Inactive Potent agonist
CACA Inactive Inactive Partial agonist
Baclofen Inactive Agonist Inactive
Phaclofen Inactive Competitive antagonist Inactive
Saclofen Inactive Competitive antagonist Inactive
Bicuculline Competitive antagonist Inactive Inactive
Picrotoxin Non-competitive 
antagonist
Inactive Competitive antagonist
TPMPA Weak antagonist Weak agonist Potent antagonist
1 Affinity of GABAB receptors for GABA is high only in the presence of calcium (Sodickson and 
Bean, 1996; Galvez et al., 2000)
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2.2.2.1. Agonists
As a  simple  rule,  GABA in  a  partially  folded conformation  and also  partially  folded 
GABA analogues can activate GABAC receptors, while the fully extended configuration of 
GABA or its analogues is needed for GABAA receptor activation (Fig. 2). Besides GABA, 
the  most  potent  GABAC receptor  agonists  are  TACA  and  muscimol.  These  two 
compounds  can  exist  in  both  conformations,  thus  being  effective  GABAA receptor 
agonists as well.
The partially  folded  cis-isomer,  CACA,  is  more  selective  and  widely  used  as  a 
GABAC receptor agonist, but it is only a partial agonist, showing 70–80% of the efficacy 
of  GABA  (Kusama  et  al.,  1993a;  Woodward  et  al.,  1993).  Unfortunately,  higher 
concentrations of CACA have been demonstrated to activate also GABAA receptors at rat 
retinal bipolar cell terminals (≥ 500 μM; Pan and Lipton, 1995) or cerebellar granule cells 
(≥ 50 μM; Wall, 2001). Moreover, CACA is a weak substrate for the GAT-3 transporter, 
and it also stimulates the passive release of GABA and β-alanine (Chebib and Johnston, 
1997).
Fig. 2. Main GABAergic molecules referred to in the text.
GABA, CACA, TACA and (+)-CAMP all act as agonists on GABAC receptors, GABA 
and TACA also on GABAA receptors. Bicuculline is a GABAA receptor antagonist and 
TPMPA a GABAC receptor antagonist,  while picrotoxin acts as a channel blocker on 
both  receptor  types.  Modified  with  permission  from Chebib  and  Johnston,  2000.  © 
American Chemical Society.
To  date,  the  most  selective  agonist  at  GABAC receptors  is  (±)-CAMP,  more 
specifically (+)-CAMP (Duke et al., 2000). The order of agonist/partial agonist potency at 
GABAC receptors can be summarized as follows: TACA > GABA > muscimol > I4AA > 
TAMP >> (±)-CAMP  ≈ CACA > isoguvacine (Chebib and Johnston, 2000). Although 
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muscimol is weaker than GABA at GABAC receptors, it is nevertheless more potent at 
GABAC than GABAA receptors expressed in Xenopus oocytes (Kusama et al., 1993a; b; 
Woodward  et  al.,  1993).  TAMP,  a  trans-enantiomer  of  (±)-CAMP,  2-MeTACA,  and 
I4AA are interesting compounds, as they seem to distinguish GABAC receptors composed 
of different ρ subunits (Kusama et al., 1993a; b; Chebib et al., 1998; Vien et al., 2002).
In addition to GABA and its analogues, recombinant ρ1 homomeric receptors have 
been shown to respond to glycine and β-alanine, albeit the EC50 being in the millimolar 
range.  As  for  glycine,  even  low  concentrations  seemed  to  potentiate  GABA-induced 
responses, but the physiological significance of the finding remains elusive (Calvo and 
Miledi, 1995).
2.2.2.2. Antagonists
The most specific GABAC receptor antagonist is TPMPA (Fig. 2), although it is also a 
weak antagonist of GABAA receptors and a weak agonist of GABAB receptors. TPMPA 
was a competitive antagonist of homo-oligomeric rat ρ1 receptors expressed in  Xenopus 
oocytes, with a Kb of around 2 μM, but slightly less potent on homo-oligomeric human ρ2 
receptors, with a Kb of around 15 μM, while rat cortical GABAA receptors expressed in 
oocytes had a Kb of around 320 μM and rat hippocampal GABAB receptors an EC50 of 
around 500 μM (Ragozzino et al., 1996). Recently, a new antagonist, (±)-cis-3-ACPMPA, 
was reported to have stronger affinity than TPMPA for human ρ2 homo-oligomers (Chebib 
et al., 2007).
The  chloride  channel  blocker  picrotoxin  (PiTX),  which  is  a  racemic  mixture  of 
picrotin and the active agent picrotoxinin, is effective on GABAA, GABAC, and glycine 
receptors,  but  GABAC receptors  are  less  sensitive  to  it  than  GABAA receptors. 
Furthermore,  native GABAC receptors  in the retina are less sensitive to  it  than homo-
oligomeric ρ1 receptors expressed in heterologous systems (Feigenspan et al., 1993; Zhang 
et al., 1995; Enz and Cutting, 1999). The inhibitory mechanism of PiTX in the ligand-
gated anion channels is a complex phenomenon and, putatively, a mixed antagonism of 
non-competitive and competitive inhibition (Woodward  et al., 1993; Qian and Dowling, 
1994; Wang  et al., 1995b; Dong and Werblin, 1996; Qian  et al., 2005). PiTX seems to 
interact with two binding sites, the emphasis of which varies between different receptor 
types (Newland and Cull-Candy, 1992; Yoon et al., 1993; Dong and Werblin, 1996; Dibas 
et al.,  2002). In GABAA receptors,  PiTX acts mainly as a non-competitive antagonist, 
whereas PiTX inhibition of GABAC ρ1 receptors is mainly competitive and use-facilitated 
(MacDonald and Olsen, 1994; Wang et al., 1995b; Dong and Werblin, 1996; Dibas et al., 
2002;  but  see Goutman and Calvo,  2004).  The relationships between PiTX block and 
certain ion channel-lining amino acids in the GABA receptors will be discussed further in 
Section 6.1. A related compound, TBPS, blocks ρ1 homo-oligomeric receptors expressed 
in  Xenopus oocytes,  but  much  more  weakly  than  GABAA receptors  (Feigenspan  and 
Bormann, 1994).
In  addition  to  ineffective  bicuculline,  other  competitive  GABAA receptor 
antagonists, such as strychnine and SR95531 (gabazine), are much weaker at inhibiting 
GABAC receptors (Woodward et al., 1993; Feigenspan and Bormann, 1994). Some more 
or less broadly used GABAA receptor agonists, like THIP (also known as gaboxadol), P4S, 
isonipecotic acid, and 3-APS, have inhibitory effects at GABAC receptors (Woodward et  
al., 1993). Several GABAB receptor agonists, such as 3-APA and 3-APMPA, are potent 
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antagonists at GABAC receptors, while phaclofen and saclofen have no effect (Woodward 
et al., 1993; Chebib et al., 1997).
2.2.2.3. Modulators
GABAC receptors are insensitive to benzodiazepines and barbiturates, known to modulate 
the responses of classical GABAA receptors (Feigenspan and Bormann, 1994). Compared 
with classical GABAA receptors, GABAC receptors are relatively insensitive to neuroactive 
steroids, but at high (μM range) concentrations steroids can modulate GABAC receptors. 
The 5α-steroids (e.g. allopregnanolone and 5α-THDOC) modulate positively both GABAA 
and GABAC receptors, while 5β-steroids (e.g. pregnanolone and 5β-THDOC) are negative 
modulators of GABAC receptors, but positive modulators of GABAA receptors (Morris et  
al.,  1999).  Although  loreclezole  is  a  very  efficient  positive  modulator  of  GABAA 
receptors, it is a potent negative modulator of ρ1 GABAC receptors, and has been described 
as a simple functional marker for them (Thomet et al., 2000). In sharp contrast to GABAA 
receptors,  ethanol seems to be a  weak competitive  inhibitor  at  ρ1 homomeric  GABAC 
receptors (Mihic and Harris, 1996). Flavonoids  were shown to inhibit ρ1 homo-oligomeric 
GABAC receptors similarly to GABAA receptors, even though these substances of plant 
origin  have  been  correlated  with  benzodiazepines  because  of  their  effects  on  sleep, 
motility and pain (Goutman et al., 2003).
Zinc  and  protons  are  physiologically  interesting  modulators,  as  they  are 
endogenously present in the brain, and zinc is putatively co-released with transmitters on 
synaptic  terminals  (Dong  and  Werblin,  1995;  1996).  Quite  opposite  to  the  GABAA 
receptor currents, extracellular acidification inhibits GABAC receptor currents; a change 
from pH 7.4 to 6.4 decreased the GABA-activated current  by 52% in HEK 293 cells 
expressing rat ρ1 homo-oligomeric receptors (Wegelius  et al., 1996). Rat ρ1 homomeric 
receptors  are  sensitive  to  protons  throughout  the  pH  range,  whereas  the  human  ρ1 
counterparts are insensitive to alkaline pH levels, implying that these receptors lack one of 
the two binding sites for protons present in rat receptors (Wegelius et al., 1996; Rivera et  
al., 2000). Zinc potently inhibits and slows down GABAC receptor currents. Modulation 
of GABAC receptors by zinc is pH sensitive, decreasing with a decrease in pH. This is 
probably due to protons and zinc ions sharing a binding site, possibly a histidine residue in 
the extracellular N-terminal domain (Calvo  et al., 1994; Chang  et al., 1995; Dong and 
Werblin, 1995; 1996; Wang et al., 1995a; Rivera et al., 2000).
Phosphorylation by PKC has also been found to down-modulate GABAC-mediated 
responses.  The mechanism seems not  to  act  through the direct  phosphorylation  of  the 
consensus  phosphorylation  sites  of  the  GABAC receptor,  acting  instead  through  the 
phosphorylation-dependent internalization of the receptor complex, with the internalized 
receptors later able to return to the cell surface (Kusama  et al., 1998; Filippova  et al., 
1999; 2000).
2.2.3. ρ subunits
GABAC receptors are believed to consist only of ρ subunits, either of a single type of ρ 
subunit as a homo-oligomeric receptor or of a mix of different ρ subunits, i.e. a hetero-
oligomeric  receptor,  sometimes  also  called  a  pseudohomo-oligomeric  receptor  to 
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distinguish it  from GABAA receptors,  which need subunits  from at least  two different 
groups of subunits (α and β). To date, three different ρ subunits have been cloned from rat 
retina  and two from human retina,  together  with  some known parts  of  the  human ρ3 
subunit sequence (reviewed by Enz, 2001 and Zhang et al., 2001). In white perch (Morone 
Americana),  a  total  of  five  ρ  subunits  have  been  sequenced  and  their  distinctive 
pharmacology demonstrated (Qian et al., 1998; Pan et al., 2005).
The  sequence  identity  across  species  is  highest  among  ρ1 subunits  (e.g.  94.1% 
between human and rat ρ1) and lowest among ρ3 subunits. In the human genome, the genes 
encoding ρ1 and ρ2 are located in the same chromosomal region (6q13-q16.3), whereas the 
gene encoding ρ3 is located in chromosome 3 (3q11-q13.3). These findings suggest that the 
ρ3 subunit has diverged earlier from a common ancestral gene (Cutting et al., 1992; Bailey 
et  al.,  1999a;  b).  Based  on  amino  acid  sequences,  ρ  receptors  are  considered 
phylogenetically old GABA receptors together with β, δ, θ, and π subunits, the sequence 
identity  between  these  subunits  being  around  40%  (Whiting  et  al.,  1999).  The 
phylogenetic  tree of GABA receptor subunits  is  seen in Figure 3.  The ancestor  of all 
ligand-gated ion channels was probably homo-oligomeric (Ortells and Lunt, 1995), which 
is still apparent in GABAC receptors. In line with archaic properties, most ρ subunits are 
found in older parts of the brain. Interestingly, the Rdl subunit of the GABA receptor of 
the fruit fly displays rather high homology at the amino acid level to the rat ρ1 subunit, 
together  with  many  similar  characteristics  (Hosie  et  al.,  1997),  further  supporting  the 
phylogenetic archaicness of ρ subunits.
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Fig. 3. The phylogenetic tree of GABA receptor subunit proteins as a cladogram.
The subunit  sequences being compared are those of the rat,  except for mouse θ. The 
distance between the subunits represents the variations of the amino acid sequences of 
the  GABA receptor  subunit  proteins  plus  the  glycine  receptor  α1 (GlyR  α1)  and  the 
nicotinic acetylcholine receptor α7 (nAChR α7) subunits. Based on amino acid sequences, 
ρ subunits are relatives to β, θ,  δ, and π subunits,  as well as to glycine α1 receptors. 
Reproduced with permission from Korpi et al., 2002. © Elsevier Science Ltd.
A  core  structure  is  conserved  among  ρ  subunits  of  all  species,  including  the 
proximal  two-thirds  of  the  extracellular  N-terminal  region  and  the  four  membrane-
spanning regions  M1–M4.  The least  conserved regions  are  the  distal  one-third  of  the 
extracellular N-terminal domain and the intracellular loop between M3 and M4 (Fig. 4; 
Zhang et al., 2001). The small differences in amino acid sequences in the channel-lining 
second transmembrane domain M2 between ρ subunits will be discussed further in Section 
6.1.
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Amino acid residues Functional effects
Q205, Y214, Y216, Y257, T260, Y263 EC50, agonist binding
H157 Zn2+ inhibition, pH
N299 Glycosylation
≈ 100 residues flanking cysteine loop Receptor assembly efficiency
P310, P314 PiTX sensitivity
P310, P314, L317 Channel gating, agonist binding
I323 Barbiturate sensitivity
Fig. 4. Schematic of the molecular structure of ρ subunits.
Highly conserved amino acid residues, shared by a large fraction of known ρ subunits, 
are shown in orange and red, while residues that are only weakly conserved among ρ 
subunits are shown in light blue, dark blue and grey. Residues known to underlie specific 
functions of GABAC receptors are indicated by a single letter amino acid abbreviation, 
followed by the position of the amino acid within the sequence (on rat ρ1 subunit). Every 
tenth amino acid is  marked by a horizontal  bar to facilitate  counting.  The functional 
effects of the labelled amino acids are indicated in the lower part of the figure. Modified 
with permission from Zhang et al., 2001. © Elsevier Science Ltd.
20
Review of the Literature
2.2.3.1. ρ1 subunit
The ρ1 subunit is easily expressed in heterologous systems, resulting in large whole-cell 
currents. While TACA and muscimol are potent partial agonists, CACA is markedly less 
potent  at  ρ1 homo-oligomeric  receptors.  The  EC50 for  CACA was  around  70  μM on 
mammalian ρ1 subunits expressed in  Xenopus oocytes,  and 131 μM when expressed in 
HEK 293 cells (Kusama  et al., 1993a; Woodward  et al., 1993; Enz and Cutting, 1999). 
The only essential difference between human and rat ρ1 seems to be pH sensitivity (see 
Section 2.2.3). Two shorter splice variants of ρ1 subunit have been found to date, ρ1Δ51 
being more sensitive to GABA and zinc, whereas ρ1Δ450 was not functional (Martínez-
Torres et al., 1998; Demuro et al., 2000). ρ1 mRNA has been discovered in retinal bipolar 
cells,  superior colliculus (SuC),  hippocampus, cerebellum, and spinal cord (Enz  et al., 
1995; Boué-Grabot et al., 1998; Enz and Cutting, 1999; Didelon et al., 2002; Rozzo et al., 
2002). Rat ρ1 homo-oligomeric receptors are more sensitive to PiTX than native GABAC 
receptors  in  the  rat  retina.  Because  of  this  and  other  pharmacological  differences, 
mammalian retinal receptors are considered to be ρ1ρ2 hetero-oligomers (Feigenspan et al., 
1993; Zhang  et al., 1995; Enz and Cutting, 1999). The single-channel conductance was 
shown to be 0.65 pS in human ρ1 and 0.2 pS in white perch ρ1A homo-oligomeric receptors 
(Wotring  et al., 1999; Zhu et al., 2007). A summary of pharmacological properties of ρ 
subunits is given in Table 3 of section 6.1.
2.2.3.2. ρ2 subunit
The ρ2 subunit has been enigmatic in GABAC receptor studies because rat ρ2 subunits did 
not form homomeric receptors when expressed alone in Xenopus oocytes, and yet, outside 
the retina, it is expressed more than ρ1. There are even areas in the central nervous system 
where it is expressed alone without any other ρ subunit (see Section 2.2.5). This has raised 
questions of the role of GABAC receptors outside the retina (Boué-Grabot  et al., 1998; 
Zhang  et  al.,  2001).  In  contrast,  mouse  and  human  ρ2 subunits  did  form homomeric 
receptors in Xenopus oocytes, although abundant ρ2 cDNA was needed for the transfection 
to get even a small current (Kusama et al., 1993b; Greka  et al., 1998; Enz and Cutting, 
1999). Human ρ2 receptors are slightly more sensitive to most agonists than ρ1 receptors. 
EC50 for CACA at human ρ2 homo-oligomers expressed in HEK 293 cells was 62 μM, 
while TACA was the most potent agonist, followed by GABA and muscimol (Kusama et  
al., 1993b; Enz and Cutting, 1999). Intriguing differences in ρ2 subunits between species 
have  been reported.  The presence  of  rat  ρ2 subunits  in  hetero-oligomeric  ρ1ρ2 or  ρ2ρ3 
receptors  has  been  suggested  to  result  in  insensitivity  to  PiTX  (Zhang  et  al.,  1995; 
Ogurusu et al., 1999), while human ρ2 homo-oligomers were more sensitive to PiTX than 
ρ1 homo-oligomers (Wang  et al.,  1995b).  The pharmacology of the ρ2 subunit  will  be 
discussed  in  more  detail  in  Sections  5.2  and  6.1.  The  single-channel  conductance  of 
mammalian ρ2 subunits has not been published, but it was 3.2 pS in white perch ρ2A, and 
3.5 pS in perch ρ2B homo-oligomeric receptors (Zhu et al., 2007).
21
Review of the Literature
2.2.3.3. ρ3 subunit
The rat ρ3 subunit, but not the white perch ρ3 subunit, formed homomeric receptors when 
expressed in  Xenopus oocytes (Shingai  et al.,  1996; Qian  et al.,  1998; Ogurusu  et al., 
1999,  Vien  et  al.,  2002).  The  ρ3 subunit  has  some  distinctive  pharmacological 
characteristics,  such as  muscimol  and TACA being more  potent  than GABA and full 
agonists.  The  potency  of  CACA  is  lower,  as  the  EC50 for  CACA  at  homomeric  ρ3 
receptors expressed in oocytes was shown to be either 139 μM (Vien et al., 2002) or 65 
μM (Ogurusu et al., 1999). Homo-oligomeric ρ3 receptors are relatively sensitive to PiTX 
(Shingai et al., 1996; Ogurusu et al., 1999). Most interestingly, MeTACA seems to be a 
moderately potent antagonist at ρ1, a partial agonist at ρ2, and inactive at ρ3 (Chebib et al., 
1998; Vien et al., 2002), whereas TAMP and I4AA act as partial agonists at ρ1 (here I4AA 
acts somewhat more potently as an antagonist, though) and ρ2, but potent, non-competitive 
antagonists at ρ3 (Vien  et al., 2002). In the adult rat brain, ρ3 mRNA was present in the 
mesencephalon (midbrain), hippocampus, cerebellum, thalamus and basal ganglia, and in 
the rat retina it has been detected in the ganglion cell layer (Ogurusu et al., 1997; 1999). 
Intriguingly,  the  expression  of  ρ3 mRNA  was  eight  times  higher  in  the  rat  brain  at 
embryonic day 16 than in the adult brain (Ogurusu et al., 1999).
2.2.4. Assembly properties
In vivo,  the ρ1ρ2 hetero-oligomeric GABAC receptor in retinal bipolar cells is the only 
combination of ρ subunits detected thus far (Feigenspan et al., 1993; Zhang et al., 1995; 
Enz and Cutting, 1999). Extensive studies by many researchers had led to the belief that 
mammalian wild-type ρ subunits do not assemble in vivo with GABAA or glycine receptor 
subunits into functional receptors, most likely due to different assembly signals in their N-
termini (reviewed by Enz, 2001). Recent accumulating evidence, however, supports the 
opposite conclusion. Mutated ρ1 subunits were found to assemble with GABAA receptor 
subunit γ2S and the glycine receptor subunits α1 and α2, but these receptors had constantly 
open ion channels (Pan  et al.,  2000). In fish, the ρ1B subunit  cloned from white perch 
retina  could  be  co-assembled  with  γ2 subunit  (either  white  perch  or  human),  and  the 
heterologously  expressed  hetero-oligomeric  receptors  had  similar  pharmacological 
characteristics to native GABAC receptors in white perch bipolar cells (Qian and Ripps, 
1999; Qian and Pan, 2002).
Immunoprecipitation  experiments,  together  with  yeast  two-hybrid  and  Xenopus 
oocyte  expression  system  methods,  demonstrated  that  protein-protein  and  functional 
interactions were possible also between rat ρ1 and γ2 subunits (Ekema et al., 2002). In the 
rat brainstem, the co-localization of α1 and ρ1 subunits was shown to be possible at light 
and electron microscopy levels, and an association of ρ1 with GABAA receptor α1 and γ2 
subunits  was  found  in  immunoprecipitation  experiments  (Milligan  et  al.,  2004).  Co-
immunoprecipitation  of  ρ1 subunits  with  α1 subunits  was  also  detected  in  cerebellum 
lysates  (Harvey  et  al.,  2006).  Of  course,  these  findings  of  co-localization  and  co-
immunoprecipitation do not necessarily imply that the receptors act together; no direct 
evidence  exists  that  co-assembly  of  functional  channels  is  true  for  any mammalian  ρ 
subunit. Still, there are several demonstrations of receptors with unusual pharmacology in 
the hippocampus, spinal cord, cerebellum, amygdala, and brainstem (discussed in more 
detail  in Section 2.2.5.),  some of which could be explained by co-assembly of ρ1 and 
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GABAA receptor subunits. It is noteworthy that no evidence for co-assembly applies to the 
ρ2 subunit, at least not yet.
To  prevent  receptors  from  laterally  diffusing  on  the  cell  membrane,  anchoring 
mechanisms  are  proposed  to  connect  the  receptors  to  cytoskeleton  proteins.  Since, 
especially in the retina, different receptors are located on different synapses within the 
same neuron (Fletcher  et al.,  1998; Koulen  et al.,  1998), a variety of selective anchor 
proteins is needed. To date, two anchoring proteins for ρ1 subunit have been identified: 
microtubule-associated  protein  MAP1B  and  glycine  transporter  splice  variant  GLYT-
1E/F. They bind to distinct sites in the long intracellular loop of ρ1, and MAP1B interacts 
to some extent with ρ2, too, but not with GABAA receptor subunits (Hanley et al., 1999; 
2000; Billups  et al., 2000). However, as no difference was apparent in retinal GABAC 
receptor staining between MAP1B-deficient and wild-type mice, MAP1B does not seem 
to be crucial for GABAC receptor clustering (Meixner et al., 2000).
2.2.5. Expression and function of native GABAC receptors
Unlike widely distributed GABAA receptors, GABAC receptors are selectively expressed. 
Of the three ρ subunits, ρ2 is the most abundant. Quantitatively, GABAC receptor subunits 
are expressed at the highest level in the retina and superior colliculus (SuC). The function 
of GABAC receptors is also best known in those two areas. All functional studies where 
CACA has been used at a concentration of 200 μM or more should be interpreted with 
caution,  as  there  are  data  showing  an  influence  on  GABAA receptors  and on  passive 
release of GABA (Pan and Lipton, 1995; Chebib and Johnston, 1997; Wall, 2001).
2.2.5.1. Retina
As visual signals pass through the retina from the photoreceptors through bipolar cells to 
the ganglion cells, they are modified by synaptic inputs from horizontal cells and amacrine 
cells,  which are GABAergic interneurons. Horizontal cells form synaptic contacts with 
photoreceptor  axon  terminals  and  bipolar  cell  dendrites  at  the  outer  plexiform  layer, 
whereas  amacrine  cells  form  synaptic  contacts  with  bipolar  cell  axon  terminals  and 
ganglion cell dendrites at the inner plexiform layer. GABAA receptors are found in almost 
every type of neuron in the retina, where they exist in a variety of subtypes with different 
compositions and locations. GABAC receptors, in contrast, are present mainly  – and  ρ1 
transcripts  exclusively– in  bipolar  cells,  primarily  at  their  axon  terminals.  ρ  subunit 
mRNA has been found in the retina of all vertebrate species investigated (reviewed by 
Enz, 2001 and Lukasiewicz et al., 2004).
In  the  rat  retina,  all  three  ρ  subunit  mRNAs  have  been  shown  by  in  situ 
hybridization to be present in the inner nuclear layer (INL), which contains the somata of 
the bipolar cells (Enz et al., 1995). Strong, punctate immunofluorescence of the ρ subunit 
protein was found in the inner plexiform layer, indicating a synaptic clustering at bipolar 
axon terminals (Enz et al., 1996). In addition, rat and chick amacrine and ganglion cells 
have  ρ2 mRNA,  and  rat  ganglion  cells  also  ρ3 mRNA (Albrecht  and  Darlison,  1995; 
Ogurusu  et  al.,  1997),  but,  to  date,  neither  ρ  protein  nor  GABAC receptor-mediated 
currents have been detected in them. Some horizontal cells in fish, but not in mammals, 
have been found to contain ρ subunit mRNA, ρ protein and functional GABAC receptors, 
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and  rod-driven  horizontal  cells  of  white  perch  are  the  only  known neurons  in  which 
GABA responses  are  mediated  exclusively  by  GABAC receptors  (Qian  and  Dowling, 
1993; 1994; Dong  et al.,  1994).  In rodent and porcine cone photoreceptors,  ρ subunit 
protein  expression was also revealed together  with  MAP1B by immunohistochemistry 
(Pattnaik et al., 2000). GABAA receptors have been shown to be often located within the 
same bipolar neurons, but not on the same synapses as GABAC receptors (Fletcher et al., 
1998;  Koulen  et  al.,  1998).  In  addition  to  synaptic  receptors,  extrasynaptic  GABAC 
receptors  have been observed on tiger  salamander and goldfish retinal  slices  by using 
GABA transporter blockers (Ichinose and Lukasiewicz, 2002; Hull  et al., 2006). During 
development, ρ2 mRNA has been reported to appear around postnatal day 9 (P9), peak at 
P15 and remain at that level through adulthood in the mouse retina, while ρ1 mRNA was 
found already at P6 (Greka  et al., 2000; Wu and Cutting, 2001). Immunostaining with 
pan-ρ antibody revealed distinct labelling of rat bipolar cells at P7, and strong, punctate, 
adult-like labelling at P19 (Koulen et al., 1998).
In the retina, GABAC receptors are involved in temporal  inhibition of bipolar cells 
(reviewed by Lukasiewicz et al., 2004). The retinal ganglion cells are excited at the onset 
and offset of light stimuli, and this transient response is caused by a delayed feedback 
inhibition from amacrine cells to bipolar cell terminals. Different types of bipolar cells 
have  been  demonstrated  to  express  different  proportions  of  GABAA and  GABAC 
receptors, the rod bipolar cells having the highest and OFF cone bipolar cells the lowest 
ratio  of  GABAC to  GABAA receptors  (Euler  and Wässle,  1998;  Shields  et  al.,  2000). 
While the excitatory pathway from rod photoreceptors  to  rod bipolar  cells  has  slower 
kinetics  than  the  cone  pathway,  the  characteristics  of  GABAC receptors  are  nicely 
matched. When taking into consideration that bipolar cells use graded potentials instead of 
action potentials as their means of signal transmission, the high-affinity, non-desensitizing 
GABACergic responses are well-suited to fine-tune these signals. In addition to temporal 
inhibition, GABAC receptors are also thought to modulate the centre-surround antagonism 
of the ganglion cells, thus participating in spatial inhibition (reviewed by Enz, 2001 and 
Lukasiewicz et al., 2004). Moreover, selective GABAC receptor inhibition has been shown 
to  increase  oscillatory  discharges  in  dimming-detector  ganglion  cells,  leading  to 
potentiated escape behaviour in frogs (Ishikane et al., 2005).
Based on the level of picrotoxin inhibition and other pharmacological properties of 
native vs. recombinant GABAC receptors, the mammalian retinal GABAC receptors are 
considered  to  be  hetero-oligomers  consisting  of  ρ1  and  ρ2 subunits  (Feigenspan  and 
Bormann,  1994;  Zhang  et  al.,  2001).  In  contrast,  the  bicuculline-insensitive  currents 
evoked in the mouse cone photoreceptors were quite sensitive to picrotoxin, suggesting 
the absence of ρ2 subunits (Pattnaik  et al., 2000). When the expression of the ρ1 subunit 
was eliminated using a gene knock-out method, the ρ2 subunit was also shown to be absent 
from the inner and outer plexiform layers and no GABAC receptor immunoreactivity was 
seen, but the morphology of the retina was normal at light microscopic level (McCall  et  
al., 2002). The rod bipolar cells in ρ1-null mice were demonstrated to lack a sustained, 
GABAC-mediated response to focally applied GABA and to brief light flashes, and no 
compensatory up-regulation of GABAA or  glycine receptors,  present normally in these 
cells,  was  detected.  Furthermore,  the  overall  visual  processing,  measured  by  a  dark-
adapted  electroretinogram (ERG),  was  altered,  namely,  the  oscillatory  potentials  were 
larger,  implying  enhanced  transmission  from bipolar  to  ganglion  cells  (McCall  et  al., 
2002).
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2.2.5.2. Visual system
Outside the retina, ρ2 is the most abundant subunit, while ρ1 and ρ3 subunits seem to exist 
at much lower expression levels (Enz et al., 1995; Boué-Grabot et al., 1998; Wegelius et  
al., 1998; Enz and Cutting, 1999; Ogurusu et al., 1999; Didelon et al., 2002; Rozzo et al., 
2002).
The superior  colliculus  (SuC) has the highest  concentration of both GABA as  a 
transmitter and ρ subunit mRNA expression in the whole brain (Mize, 1992; Boué-Grabot 
et al., 1998; Wegelius et al., 1998). SuC is a multi-layered midbrain nucleus involved in 
the  control  of  saccadic  eye  movements.  In  the  superficial  grey  layer  (SGL)  of  SuC, 
excitatory retinal and cortical afferents activate not only efferent projection neurons to the 
thalamus  and  brainstem but  also  a  large  number  of  local  inhibitory  interneurons  that 
induce  feed  forward  inhibition  to  the  projection  neurons.  In  the  SGL,  inhibitory 
interneurons  comprise  about  half  of  the  neuron  population  (Mize,  1992),  and  strong, 
punctate ρ-immunolabelling is largely restricted to this layer (Pasternack et al., 1999). In 
contrast to the retina, the physiological role of GABAC receptors in the SuC is excitation, 
or  rather  disinhibition,  of  the  SGL  projection  neurons  (Arakawa  and  Okada,  1988; 
Pasternack et al., 1999; Boller and Schmidt, 2001; Schmidt et al., 2001). This is consistent 
with  the  preferential,  or  even  exclusive,  location  of  these  receptors  in  the  local 
GABAergic interneurons (Pasternack et al., 1999; Schmidt et al., 2001). GABAC receptors 
may also contribute to GABA-induced long-term potentiation (LTP) in the SuC (Platt and 
Withington, 1998).
In the SGL of SuC, ρ1 subunits co-localize only partly with the synaptic  protein 
synaptophysin (Clark  et al., 2001). In agreement with this, no GABAC-driven inhibitory 
postsynaptic  currents  were  found  in  SGL  piriform  or  stellate  cells  with  optic  fibre 
stimulation, even though GABAC receptors on these cells were activated with exogenous 
agonists  (Schmidt  et  al.,  2001).  Furthermore,  only  a  minor  portion  of  spontaneous 
inhibitory  postsynaptic  currents  were  bicuculline-resistant  or  TPMPA-sensitive  in 
collicular slices (Boller and Schmidt, 2003; Kirischuk et al., 2003). These findings suggest 
that,  in  addition to  synaptic  receptors,  a  subpopulation  of  GABAC receptors  could  be 
extrasynaptic and activated by the spillover of the synaptically released GABA (Boller and 
Schmidt, 2003; Kirischuk et al., 2003).
At P0, ρ1 and ρ2 mRNAs were shown to be expressed in chick optic tectum, the 
avian counterpart  of the SuC (Albrecht  et al.,  1997). In the SuC of the rat,  ρ1 protein 
expression was seen as early as  from  birth (Clark  et  al.,  2001).  In  neonatal  rat  SuC 
cultures,  on the other  hand,  no functional  GABAC receptors  appeared to contribute  to 
excitatory  GABA  responses  (White  and  Platt,  2002).  With  single-cell  patch-clamp 
recordings, functional GABAC receptors could be detected already at P4, but they did not 
significantly influence the response at the cell population level until the third postnatal 
week,  putatively  due  to immature  local  GABAergic  connections  (Boller  and Schmidt, 
2001).
Strikingly,  GABAC receptor  expression  has  been  found  in  many  brain  regions 
related to vision: SuC, dorsal lateral geniculate nucleus (dLGN), pretectal nucleus of the 
optic tract (NOT), median terminal nucleus of the accessory optic tract (MTN), and the 
sixth layer of the visual cortex (Boué-Grabot et al., 1998; Wegelius et al., 1998; Enz and 
Cutting, 1999; Ogurusu  et al.,  1999; Pasternack  et al.,  1999). These subcortical  nuclei 
expressing ρ subunits are all retinorecipient (Van der Want et al., 1992). The dLGN relays 
visual information to the cortex, while NOT and MTN are involved in the generation of 
optokinetic nystagmus. Punctate  ρ-immunoreactivity surrounding putative unstained cell 
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bodies has been illustrated in the dLGN, NOT and MTN (Wegelius, 2000). Similarly to 
SuC,  in  the  dLGN,  GABAC receptors  have  been  demonstrated  to  be  localized  in 
GABAergic interneurons and, in line with this, to mediate disinhibition of geniculocortical 
relay cells (Zhu and Lo, 1999; Schlicker et al., 2004). Electrical stimulation of MTN was 
shown to cause bicuculline-insensitive GABAergic responses in the NOT (Van der Togt 
and Schmidt, 1994). Similarly to SuC, at least part of the GABAC receptors seem to be 
located away from synaptic sites in the NOT (Boller and Schmidt, 2003).
2.2.5.3. Hippocampus
Outside  the  visual  system,  the  clearest  GABAC receptor  mRNA  expression  and  ρ 
immunolabelling have been found in the hippocampus, where all three ρ subunit mRNAs 
have  been  detected  by  RT-PCR,  ρ2 being  predominant  (Boué-Grabot  et  al.,  1998; 
Wegelius  et al., 1998; Didelon  et al., 2002). With single-cell RT-PCR of hippocampal 
cultures and slices, most pyramidal cells were shown to co-express all three  ρ mRNAs, 
while granule cells seemed to express mainly ρ3 mRNA (Liu  et al., 2004). On the other 
hand,  when the single-cell  RT-PCR approach was used for individual  CA3 pyramidal 
neurons, only very few exhibited  ρ2 mRNA (Didelon  et al., 2002).  In situ hybridization 
displayed ρ2 mRNA in the adult rat CA1 pyramidal layer (Wegelius et al., 1998; Ogurusu 
et al., 1999), but also in the interneurons throughout the different hippocampal subfields 
(Rozzo et al., 2002), the latter group reporting also overlapping, but weaker expression of 
ρ1 mRNA. Immunohistochemistry on adult hippocampal sections showed a few positive 
scattered  interneurons  and  weakly  positive  dentate  gyrus  granular  cells  and  CA1 
pyramidal neurons (Rozzo et al., 2002).
Postnatally,  ρ1 and ρ2 transcripts have been detected at P5 and P8 with RT-PCR in 
the CA1 area (Boué-Grabot et al., 1998; Wegelius et al., 1998; Ogurusu et al., 1999). In 
contrast,  Rozzo and co-workers (2002) could detect  ρ1 and  ρ2 mRNAs in the  stratum 
pyramidale of all CA regions and in the granule cell layer of the dentate gyrus at a very 
low level at P1. At P7, both subunit transcripts were strongly expressed in the  stratum 
pyramidale of  the  CA1  and  CA4  areas  and  the  hilus,  but  also  in  cells,  most  likely 
interneurons, located within the strata oriens and radiatum of the CA1 and CA3 subfields, 
whereas after the first postnatal week the expression was downregulated (Rozzo  et al., 
2002). Didelon  et al. (2002) demonstrated all three  ρ subunits at P2 with RT-PCR, but 
they reported upmodulation of ρ1 and ρ2 in the postnatal rat hippocampus.
Information on GABAC receptor function in the developing hippocampus has been 
discrepant.  In  the  early  postnatal  hippocampus,  some bicuculline-insensitive  responses 
were  seen  in  the  CA3 area,  disappearing  after  the  second postnatal  week (Strata  and 
Cherubini, 1994; Martina  et al., 1995). As these receptors  1) had lower agonist affinity 
and 2) similar single-channel conductance as conventional GABAA receptors, and 3) they 
were potentiated by zinc at low concentrations,  but  4) neither distinguished by CACA 
(although  300  μM  or  more  was  used)  5) nor  antagonized  by  TPMPA  (Strata  and 
Cherubini, 1994; Martina  et al., 1995; 1996; Didelon  et al., 2002), they do in fact not 
resemble GABAC receptors. 
Three groups have studied cultured hippocampal neurons taken from rat brains at 
different ages. In hippocampal neurons taken from the brains of 17-day-old rat embryos 
and cultured for 10 – 14 days, a clear effect on ammonia-induced accumulation of chloride 
by CACA, TPMPA and PiTX, but not bicuculline was detected, indirectly indicating the 
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presence of functional native GABAC receptors (Irie et al., 2001). In neurons taken from 
the  brains  of  1-  to  2-day-old  rat  pups,  only  a  negligible  fraction  of  currents  were 
bicuculline-insensitive, whereas CACA-sensitive currents were not seen at all (Cheng et  
al., 2001a; b). In neurons from P3 to P5, a bicuculline-insensitive current was observed, 
but this current deactivated rapidly and was not blocked by GABAC receptor competitive 
antagonist 3-APA (Filippova  et al.,  2001). The same group did not detect bicuculline-
insensitive currents in cultured hippocampal slices from P7. Surprisingly, an unusual type 
of GABA receptor was found in pyramidal cells of acute hippocampal slices from P8 to 
P18, as it was activated by CACA (100 – 1000 μM), but inhibited by both TPMPA (60 
μM) and bicuculline (30 μM), thus possessing pharmacological properties of GABAA and 
GABAC receptors (Hartmann et al., 2004).
Few  studies  are  available  to  date  on  functional  GABAC receptors  in  the  adult 
hippocampus.  In  acutely  isolated  rat  hippocampal  pyramidal  neurons,  a  population  of 
GABA receptors was found to have a high affinity for GABA and to be inhibited by 
protons at physiological pH levels (Pasternack et al., 1996), resembling the properties of 
GABAC receptors (Rivera et al., 2000). In the guinea-pig hippocampus, a large increase in 
the holding current of pyramidal neurons in the CA1 area was detected with a perfusion of 
50 μM CACA, and this increase was not affected by pentobarbital, consistent with the 
presence of GABAC receptors in pyramidal neurons (Semyanov and Kullmann, 2002). In 
hippocampal  interneurons,  on  the  other  hand,  the  same authors  demonstrated  atypical 
GABA responses; these responses had a relatively small single-channel conductance and 
were somewhat insensitive to 100 μM PiTX and sensitive  to 50 μM CACA, but also 
sensitive  to  10  μM bicuculline  and  100  μM pentobarbital  (Semyanov  and  Kullmann, 
2002).
The ionotropic GABA receptors mediating fast inhibitory synaptic currents in the 
hippocampal CA1 area have been shown to be bicuculline-sensitive in a number of studies 
(Collingridge et al., 1984; Lambert et al., 1991), indicating that only GABAA receptors are 
present  in  these  synapses.  However,  slowly  activating  GABA  responses  evoked  by 
multiple synaptic stimulations have been reported in the hippocampal CA1 area. These 
responses were only partially blocked by a GABAB receptor antagonist, and hence, could 
be mediated by GABAC receptors (Thomson and Destexhe, 1999).
2.2.5.4. Cerebellum
The question  of  GABAC receptors  in  the  cerebellum is  controversial.  In  the  adult  rat 
cerebellum,  ρ1 and  ρ2 mRNAs  were  found  in  Purkinje  and  basket  cells  by  in  situ 
hybridization (Boué-Grabot  et al., 1998; Rozzo  et al., 2002), and RT-PCR revealed the 
same ratio between ρ1 and ρ2 mRNA (1:2) in the cerebellum and retina (Boué-Grabot et  
al., 1998; Enz and Cutting, 1999). In addition, the ρ2 subunit was cloned from the bovine 
cerebellum, the encoded receptors being functional in Xenopus oocytes (López-Chavez et  
al., 2005). Immunocytochemical studies revealed  ρ protein expression predominantly in 
Purkinje  cell  somata  and proximal  dendritic  compartments  (Boué-Grabot  et  al.,  1998; 
Harvey et al., 2006).
CACA was found to bind to adult rat cerebellar membranes, and this binding could 
not be displaced by bicuculline or baclofen (Drew et al., 1984; Drew and Johnston, 1992). 
Later  on,  α6 subunit-containing  GABAA receptors  were  demonstrated  to  have  a  low 
sensitivity  to  bicuculline  (Thompson  et  al.,  1996);  thus,  these  receptors  may  have 
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contributed  to  earlier  findings.  In  cultured  cerebellar  granule  cells,  both  bicuculline-
sensitive and -insensitive receptors were found, but the latter group had lower affinity for 
GABA, unlike GABAC receptors (Martina  et al., 1997). More recently,  50 – 1000 μM 
CACA was shown to activate α6 subunit-containing GABAA receptors in the granule cells 
of cerebellar slices. As CACA and GABA currents were blocked by bicuculline, PiTX and 
furosemide, but not TPMPA, no signs of GABAC receptors were visible (Wall, 2001). In 
cerebellar Purkinje cells, however, no α6 subunit-containing GABAA receptors have been 
detected (Wisden et al., 1996), but, still, CACA (50 – 500 μM) was able to evoke non-
desensitizing  currents  inhibited  by  both  TPMPA  (100  μM)  and  bicuculline  (50  μM; 
Harvey  et  al.,  2006).  While  co-immunoprecipitation  studies  suggested  that  ρ subunits 
could  form complexes  with  GABAA receptor  α1 subunits  in  the  cerebellar  cortex,  the 
authors speculated about a receptor population with a mixed pharmacology. Evidence for 
extrasynaptic GABAC receptors was sought, but not found, as TPMPA inhibited phasic, 
but not tonic transmission in Purkinje cells (Harvey et al., 2006).
2.2.5.5. GABAC receptors in other brain areas and functions
In the rat central amygdala, some GABA-activated currents that were relatively insensitive 
to bicuculline and PiTX were found. As these responses were antagonized by TPMPA, but 
also by diazepam and flurazepam, the possibility of the co-assembly of ρ subunits with 
GABAA receptor subunits  has been tendered (Delaney and Sah,  1999).  These atypical 
currents  were  detected  on  the  dendrites  of  neurons,  where  also  conventional  GABAA 
receptor currents were present (Delaney and Sah, 2001). Thus far, no molecular biology 
data exist on GABAC receptor subunit distribution in the amygdala.
In  the  rat  brainstem,  RT-PCR has  revealed all  three  ρ mRNAs,  whereas  in  situ 
hybridization showed only ρ1 mRNA, suggesting its predominance (Milligan et al., 2004). 
ρ1 mRNA was seen on all neurons in the dorsal vagal nucleus (DVN) and on about two-
thirds of neurons in nucleus tractus solitarii, and this neuronal localization was confirmed 
by  immunohistochemistry.  Furthermore,  immunoelectron  microscopy  showed  ρ1 
immunoreactivity adjacent to the postsynaptic side of the synaptic junction. CACA (100 – 
800 μM) was shown to depolarize DVN neurons, but the responses were inhibited by both 
TPMPA  (40  –  160  μM)  and  bicuculline  (10  μM)  and  potentiated  by  sodium 
pentobarbitone and zolpidem, thus displaying unusual pharmacology with characteristics 
of GABAC and GABAA receptors. Moreover, the authors demonstrated the possibility of 
co-localization of α1 and ρ1 at an identical site on the postsynaptic membrane in DVN 
neurons by immunoelectron microscopy and co-immunoprecipitation of α1, γ2 and ρ1 in 
brainstem lysates (Milligan et al., 2004).
In  the early postnatal  rat  brainstem, more precisely in  the rostral  nucleus of  the 
solitary tract, bicuculline-insensitive, PiTX-sensitive responses were detected in the first 
three postnatal weeks, implying the transient expression of functional GABAC receptors 
(Grabauskas  and  Bradley,  2001).  In  addition,  in  brainstem auditory  neurons  (nucleus 
magnocellularis)  of  the  young  (P5  –  P14)  chick,  some bicuculline-insensitive  GABA 
responses were shown (Hyson et al., 1995).
In the bovine caudate nucleus of the basal ganglia, ρ1 and ρ2 mRNAs, and ρ protein 
were demonstrated together with cloned ρ1 receptors expressed in oocytes showing typical 
GABAC receptor properties (López-Chavez et al., 2005; Rosas-Arellano et al., 2007). The 
sensitive  RT-PCR has  also  indicated  ρ2 mRNA in  the  rat  epithalamus,  thalamus  and 
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mesencephalon (Enz et al., 1995; Ogurusu  et al., 1999), and in situ hybridization in the 
pars compacta of the substantia nigra (Ogurusu et al., 1999), but no signs of functional 
GABAC receptors have thus far been detected.
Interestingly, TPMPA has been demonstrated to have an influence on sleep in  in  
vivo studies. Rats were given infusions of different TPMPA concentrations into the fourth 
ventricle  and  their  sleep-waking  behaviour  was  scored  according  to 
electroencephalography  (EEG)  and  electromyography  (EMG).  TPMPA  noticeably 
increased non-active waking and decreased sleep, both slow-wave sleep and REM sleep 
(Arnaud  et al.,  2001). In addition, bilateral infusion of TPMPA in the  locus coeruleus 
inhibited  REM  sleep  (Gottesmann,  2004).  These  effects  can  be  hypothesized  to 
correspond to GABAC receptors in the brainstem dorsal raphe and locus coeruleus nuclei. 
This hypothesis is supported by the finding that a microperfusion of PiTX, but not of 
bicuculline, onto the dorsal raphe blocked REM sleep (Levine and Jacobs, 1992; Nitz and 
Siegel,  1997;  Gottesmann,  2002;  but  see  Gervasoni  et  al.,  2000).  The  sleep-waking 
generating  processes  have  been  shown  to  be  modulated  by  various  receptor  systems, 
including GABA and all  three of its receptor classes (reviewed by Gottesmann, 2002; 
2004).
Contrary  to  GABAA receptors,  GABAC receptors  seem  to  have  an  inhibitory 
function in short-term memory formation in young chicks, as selective GABAC receptor 
antagonists  TPMPA and  P4MPA injected  into  the  multimodal  association  area  of  the 
forebrain had an enhancing effect (Gibbs and Johnston, 2005). In agreement, CGP 36742, 
an antagonist of both GABAB and GABAC receptors, had a positive influence on learning 
and memory in mice,  rats, and monkeys,  unlike selective GABAB receptor antagonists 
(Froestl et al., 1995; Genkova-Papakova et al., 2000).
2.2.5.6. Spinal cord
Although the story of GABAC receptors originated in the spinal cord, their function in this 
structure has only recently been studied in more detail. RT-PCR displayed expression of 
all three  ρ mRNAs,  ρ2 being the strongest (Enz et al., 1995; Wegelius, 2000). In  in situ 
hybridization  studies,  motoneurons  were  labelled  on  the  newborn  sections,  but  both 
interneurons and motoneurons were labelled at  P7 and in adults,  the  ρ2 staining being 
stronger than ρ1. Adult spinal neurons displayed strong  ρ-immunostained puncta in their 
dendrites and cell somata, where ρ1 and ρ2 mRNAs were also found (Wässle et al., 1998; 
Rozzo  et al., 2002). In addition, immunoreactivity displayed strong membrane labelling 
on lamina I and II neurons of the superficial dorsal horn (Zheng  et al., 2003). Central 
nociceptive neurons are located in lamina I and II, where afferent fast and slow pain fibres 
also predominantly terminate.  Many of the neurons in lamina I respond exclusively to 
noxious stimulation and project to higher brain centres, whereas many lamina II neurons 
are interneurons modulating the pain sensation.
Neonatal  spinal  motoneurons  were  shown  to  have  functional  GABAC receptors, 
which, although responding only to exogenous GABA and not to synaptic activity evoked 
by  dorsal  root  stimulation  (Rozzo  et  al.,  2002),  contributed  to  spontaneous  bursting 
activity  following blocking of  GABAA and  glycine  receptors  (Rozzo  et  al.,  1999).  In 
lamina II neurons, a sustained, bicuculline-insensitive component of GABA current was 
detected,  but as it  was potentiated  by thiopental  and flunitrazepam, and unaffected by 
I4AA (Park et al., 1999), conventional GABAC receptors are not involved.
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The cell bodies of all of the primary nociceptive neurons are located in the dorsal 
root ganglia (DRG). In the adult DRG, all three ρ mRNAs were found at relatively high 
levels by RT-PCR (Wegelius et al., 1998; Wegelius, 2000), and ρ-immunoreactivity was 
shown to be quite uniform, labelling the DRG neurons of different sizes (Zheng  et al., 
2003). In DRG, some bicuculline-resistant GABA-responses have been detected, but not 
further identified (Valeyev et al., 1996).
The expression pattern suggested a role for the ρ1 subunit in modulating spinal cord 
pain input and transmission, and this was nicely demonstrated in vivo with the generation 
of ρ1–/– knock-out mice. In mice completely lacking the ρ1 (and, at least in spinal cord, also 
ρ2) subunit, the gross neuroanatomical structure of spinal cord and DRG was unchanged 
and the animals seemed healthy, but the spinal cord response to electric stimulation was 
markedly  less  sensitive  to  GABA.  Moreover,  the  mechanical  pain  threshold  was 
significantly decreased, putatively causing increased sensitivity and overexcitation of the 
primary nociceptive neurons, thus resembling allodynia in humans (Zheng et al., 2003).
2.2.5.7. GABAC receptors outside the central nervous system
In the rat pituitary gland, ρ1 and ρ2 mRNAs were shown, the level of the former being 
considerably higher. Furthermore, ρ-immunoreactivity was found on thyrotropin-secreting 
cells  and  growth-hormone-secreting  cells,  and  bicuculline-insensitive  but  desensitizing 
currents were detected using patch-clamp recordings (Boué-Grabot  et al., 2000; Gamel-
Didelon et al., 2003).
Intriguingly,  a  peripheral,  subcutaneous  administration  of  CACA to  a  hind  paw 
elicited  a  local  antinociceptive  effect  in  the  paw  pressure  test,  and  this  effect  was 
antagonized by TPMPA and picrotoxin, but not by potassium channel blockers (Reis and 
Duarte, 2007).
In the myenteric plexus of the rat gastrointestinal tract, the expression of all three ρ 
subunit mRNAs and ρ-immunolabelling mainly on intrinsic sensory and inhibitory motor 
neurons were evident (Fletcher  et al.,  2001). Functional  native GABAC receptors have 
been demonstrated on gut neuroendocrine tumour cell  line STC-1 cells,  where CACA 
induced calcium influx and increased cholecystokinin secretion, effects antagonized by 
TPMPA (Jansen et al., 2000). In the neurons of the rat major pelvic ganglia, both GABAA 
and GABAC receptors were shown to have distinctive roles in mediating biphasic GABA 
responses  (Akasu  et  al.,  1999).  The  sensitive  RT-PCR  has  also  shown  ρ2 mRNA 
expression in the heart, liver, gonadal endocrine tissues, adrenal gland and placenta, but no 
signs of functional GABAC receptors have been revealed thus far (Boué-Grabot  et al., 
1998; Akinci and Schofield, 1999; Rozzo et al., 2002).
2.3. Depolarizing GABA responses
GABA is known to have an excitatory action in the developing nervous system because 
the reversal potential for chloride (ECl) is more depolarized than the resting membrane 
potential and the action potential threshold in immature neurons (reviewed by Ben-Ari, 
2002).  The  main  underlying  factors  leading  to  a  depolarization,  instead  of  a 
hyperpolarization, when GABAA receptors are activated, are the distinctive contributions 
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of cation-chloride co-transporters in immature neurons compared with mature neurons. 
First to appear in cells is the sodium-potassium-chloride co-transporter NKCC1, which 
raises the intracellular chloride concentration and is downregulated during development 
(Plotkin et al., 1997), while the potassium-chloride co-transporter KCC2, which actively 
lowers the intracellular chloride concentration, is upregulated after the first postnatal week 
(Rivera et al., 1999). Probably, the role of this depolarization is to promote the growth of 
synapses and neuronal networks, as GABA can act as a trophic factor and GABAergic 
synapses appear first in the development (Owens and Kriegstein, 2002). During most of 
the embryonic phase, GABA-mediated giant depolarizing potentials provide the majority 
of the activity,  as the network is not sufficiently developed to generate more elaborate 
patterns  of  activity  (Khazipov  et  al.,  2001;  Crépel  et  al.,  2007).  Gradually  and in  an 
activity-dependent manner, the expression of KCC2 begins, chloride levels decrease and 
GABA responses become predominantly hyperpolarizing (reviewed by Ben-Ari, 2002).
There are a few situations where GABA mediates depolarizing responses also in 
adult neurons. Already decades ago, GABA was shown to have an excitatory action on 
DRG cells (Eccles  et al.,  1963),  and, more recently,  DRG cells  were demonstrated to 
maintain  high  expression  of  NKCC1  and  low  expression  of  KCC2  throughout 
development  (reviewed  by  Stein  and  Nicoll,  2003).  Furthermore,  under  certain 
circumstances, GABAergic transmission on any cortical neuron can have an excitatory 
action, and the net effect depends not only on the resting membrane potential, but also on 
the location and timing of the GABAergic input relative to the excitatory (glutamatergic) 
input  (Gulledge and Stuart,  2003; Lamsa and Taira,  2003).  In temporal  lobe epilepsy, 
depolarizing GABA responses have been implicated in pathological,  interictal epileptic 
activity (Cohen et al., 2002).
A special case of depolarizing GABA responses is the biphasic, prolonged response 
following vigorous stimulation of hippocampal interneurons at stratum radiatum (Kaila et  
al., 1997; Smirnov et al., 1999; Voipio and Kaila, 2000; Ruusuvuori et al., 2004; Rivera et  
al.,  2005).  A  high-frequency  stimulation  (HFS)  train  in  the  presence  of  ionotropic 
glutamate  receptor  antagonists  results  in  a  massive,  synchronous  excitation  of 
hippocampal  pyramidal  neurons,  which  is  either  named  GABA-mediated  depolarizing 
postsynaptic potential (GDPSP; Fig. 7 in Materials and methods) or non-synaptic potential 
(GDNSP).  The mechanisms behind this phenomenon have been debated (Staley  et al., 
1995; Perkins, 1999; Staley and Proctor,  1999; Voipio and Kaila,  2000), but the most 
accepted theory suggests an essential role for bicarbonate-ion and the enzyme carbonic 
anhydrase (Ruusuvuori et al., 2004; Rivera et al., 2005). This qualitative change of action 
of GABAergic transmission takes place not only in response to HFS, but, putatively, also 
during epileptiform activity  and the induction of LTP,  showing once more the unique 
plasticity of neurotransmission under different conditions (Rivera et al., 2005).
31
Aims of the Study
3. Aims of the Study
A decade of intensive studies on ρ subunits and GABAC receptors had revealed a great 
deal of information, especially on their molecular structure, but less on their function and 
very little on their role outside the retina and superior colliculus (SuC). In this work, we 
aimed to elucidate the expression of ρ subunits in the postnatal brain, the characteristics of 
ρ2 homo-oligomeric receptors, and the function of GABAC receptors in the hippocampus. 
The aims of the individual studies were as follows.
I. Although  the  distribution  of  ρ  subunit  mRNAs  in  the  adult  brain  had  been 
examined  using  RT-PCR and  in  situ hybridization,  information  on  the  developmental 
regulation was scattered and incomplete. We wanted to investigate the expression of all 
three  known  ρ  subunits  in  the  brain  throughout  the  postnatal  period,  with  particular 
emphasis on developmental changes in subunit expression in the hippocampus and SuC. 
In  these areas,  our  aim was also to  get  a  quantitative  assessment  of  putative  GABAC 
receptor subunit combinations.
II. Previous work done on Xenopus oocytes had suggested that rat ρ2 subunits do not 
form functional homo-oligomeric GABAC receptors but need ρ1 or ρ3 subunits to form 
hetero-oligomers  with  relatively  low  sensitivity  to  PiTX.  Because  previous  data  had, 
however, indicated a much higher expression level for the ρ2 subunit transcripts than for ρ1 
or ρ3 in the brain, we wanted to test whether ρ2 subunits can be functionally expressed as 
homo-oligomers in mammalian cells. In addition, we aimed to characterize the properties 
of these homo-oligomeric receptors, especially their picrotoxin sensitivity.
III. As  both  GABAC receptor  subunit  mRNA  and  protein  were  shown  to  be 
expressed in the stratum pyramidale in the CA1 area of the adult rat hippocampus, but no 
conclusive evidence for functional receptors there had been demonstrated, we wanted to 
study  the  effects  of  GABAC receptor  agonists  and  antagonists  on  responses  of  the 
hippocampal neuron population to electrical stimulation. Next, we aimed to display the 
activation  of  the  GABAC receptors  by  synaptically  released  GABA.  Fast  inhibitory 
synaptic  currents  in  the  hippocampal  CA1  area  had  previously  been  shown  to  be 
exclusively mediated by GABAA receptors, but we hypothesized that GABAC receptors in 
hippocampal CA1 neurons might be extrasynaptic and possibly activated by the spillage of 
synaptic GABA.
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4. Materials and Methods
Detailed descriptions of the materials and methods applied in this work are given in the 
original  publications  (see  Table  2  for  references).  A  variety  of  methods  focusing  on 
different aspects were chosen to improve the reliability of the results. More specifically, 
with  in  situ hybridization  one  can  detect  a  specific  mRNA  in  a  section,  whereas 
immunocytochemistry localizes certain proteins in a given tissue section. Quantitative RT-
PCR quantifies mRNA expression, but as RT-PCR is a very sensitive method, it should 
always be combined with other approaches to avoid physiologically less relevant results. 
Patch-clamp recordings in transfected cells  enable detailed characterization of receptor 
subunits, while recordings in brain slices yield information on the function of the whole 
neuronal network in a given structure. Because the hippocampal CA1 area possesses a 
wide  variety  of  transmitter  receptors,  it  is  crucial  to  combine  the  results  from  slice 
recordings with the data from other experiments in order to see the contribution of GABAC 
receptors in the hippocampus.
Table 2. The methods used in the original studies.
Method Study
In situ hybridization I
Quantitative RT-PCR I
Immunocytochemistry I
Expression of ρ subunits in HEK 293 cells II
Immunofluorescence staining II
Patch-clamp recordings in transfected cells II
Hippocampal slices III
Extracellular recordings in brain slices III
Intracellular recordings in brain slices III
As an exception, the method of preparing hippocampal slices is not fully described 
in  III and is given here.  P21 – P47 Wistar rats were anaesthetized with a mixture of 
ketamine  and medetomidine  given intraperitoneally.  They were transcardially  perfused 
with ice-cold artificial cerebrospinal fluid (ACSF) containing (in mM) 124 NaCl, 5 KCl, 
1.25 NaH2PO4, 26 NaHCO3, 2 MgSO4, 2 CaCl2, and 10 glucose, continuously gassed with 
5% CO2 – 95% O2. Within 4 min of perfusion, the brains of the animals were cooled down 
to diminish the metabolic rate and to prevent the degradation of brain tissue. The rats were 
then decapitated with a guillotine and the brains were exposed within 60 s. The tissues 
were placed in ice-cold, previously gassed, low NaCl solution containing (in mM) 3 KCl, 
8 MgCl2, 0.5 CaCl2, 1.25 NaH2PO4, 26 NaHCO3, 25 glucose, and 230 sucrose, both during 
the exposition of the brains and while 400-μm-thick transverse slices of the hippocampi 
were made using a vibratome. The slices were allowed to recover in continuously gassed 
ACSF at 32°C for 30 min and then at room temperature for at least 30 min before use.
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During  the  recordings,  a  stimulation  electrode  was  placed  in  the  CA1  area  to 
stimulate the Schaffer collaterals in the stratum radiatum (Fig. 5). Extracellular responses 
(Fig.  6)  were  recorded  from the  stratum pyramidale.  Membrane  input  resistance  was 
measured in intracellular recordings using injections of hyperpolarizing current. GDPSPs 
(Fig. 7) were elicited by HFS and recorded inside pyramidal neurons. All of the chemicals 
used  in  patch-clamp  and  slice  recordings  are  listed  in  Table  3  together  with  the 
concentrations used.
Fig. 5. Schematic of the recording site in the hippocampal slice.
The stimulus electrode was placed in the stratum radiatum and the recording electrode in 
the  stratum pyramidale.  HFS trains were given closer to the pyramidal  neuron, from 
which the voltage was recorded.
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Fig. 6. An example of the extracellular field potential response showing the pEPSP and 
pSpike referred to in Section 5.3.1.
Fig. 7. High-frequency stimulation of local  inhibitory interneurons in the presence of 
ionotropic  glutamate  receptor  and GABAB receptor  blockers  evokes  GABA-mediated 
long-lasting depolarizing responses. An example of the GDPSP response showing the 
different  parameters  referred  to  in  Section  5.3.3.  Reproduced  with  permission  from 
Alakuijala et al., 2006. © Federation of European Neuroscience Societies and Blackwell 
Publishing Ltd.
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Table 3. Chemicals used in different kinds of electrophysiological recordings.
Drug Effect Concentration(s) used
AP5 Ionotropic glutamate receptor 
antagonist
40 μM (intracellular recordings)
BIM GABAA receptor antagonist 1–5 μM (extracellular recordings),
100 μM (intracellular recordings)
CACA GABAC receptor agonist 1–50 μM (patch-clamp recordings),
0.75–5 μM (extracellular recordings),
2–20 μM (intracellular recordings)
CGP 46381 GABAB receptor antagonist 50–100 μM (intracellular recordings)
CNQX Ionotropic glutamate receptor 
antagonist
20 μM (intracellular recordings)
GABA GABA receptor agonist 0.3–100 μM (patch-clamp recordings)
PiTX GABAA and GABAC receptor 
blocker
0.01–100 μM (patch-clamp recordings), 
100 μM (intracellular recordings)
SKF 89976A GABA transporter blocker 10 μM (intracellular recordings)
TPMPA GABAC receptor antagonist 1–10 μM (extracellular recordings),
10–50 μM (intracellular recordings),
50–500 μM (intracellular recordings 
with BIM)
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5. Results
5.1. Expression of ρ subunits in the developing rat brain (I)
5.1.1. ρ2 subunit mRNA expression in the developing rat retina and brain
Of  the  three  GABAC receptor  ρ  subunits  tested  in  the  adult  rat  brain,  our in  situ 
hybridization revealed only ρ2 subunit mRNA. While the ρ1 in situ probe gave positive 
hybridization in the adult retina, the ρ3 probe was negative in both the adult retina and 
brain.
In  the  developing  retina,  no  expression  of  ρ2 mRNA was  seen  at  P0,  but  high 
expression could be detected in the inner nuclear layer (INL) of the retina at P8, P14, and 
P60 (Fig. 1A in  I). These findings are in line with previous reports, demonstrating the 
specificity of our hybridization probe.
In the developing superior colliculus (SuC),  in situ hybridization displayed strong 
expression of ρ2 mRNA in the superior grey layer (SGL) from P8 to P60, the expression 
level being maximal in the adult SuC (Fig. 1B in  I). Already at the time of birth, weak 
expression was seen, limited to the superficial border of SuC.
Between  P8 and  P60,  ρ2 transcripts  were  also  visible  in  the  CA1 region  of  the 
hippocampus (Fig.  1B in  I).  The hippocampal  expression level  increased during early 
postnatal  development,  was  maximal  after  the  second  postnatal  week  and  decreased 
somewhat towards adulthood, when it was clearly less prominent than in the SuC.
In postnatal developmental stages, ρ2 subunit mRNA was also apparent in various 
other parts of the visual system: NOT from the second postnatal week to adulthood (Fig. 
1B in I), dLGN at P60, and MTN from P14 to P60. In addition, ρ2 transcripts were seen in 
three layers of the adult frontal cortex.
5.1.2. Quantitative ρ subunit mRNA detection in the hippocampus and SuC
qRT-PCR results  indicated expression of all  three ρ subunit  mRNAs at varying levels 
from the newborn to adult hippocampus and SuC (Fig. 4 in  I). In the hippocampus, the 
highest expression levels were evident for ρ2 transcripts, confirming the observation made 
with in situ hybridization. In the hippocampus, ρ3 was expressed at a higher level than ρ1, 
with the exception of P14, while in the SuC the opposite was observed, except at P7, when 
ρ3  was more abundant. Interestingly, the total amount of ρ subunit mRNA peaked at P7 
and P21 in both the hippocampus and SuC. These findings are consistent with our in situ 
hybridization results during the postnatal development, with the only exception occurring 
at P14, when qRT-PCR showed decreased, but in situ increased, expression levels in both 
the hippocampus and SuC.
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5.1.3. ρ subunit protein expression in the adult brain
An antibody recognizing all  three ρ subunits  was used to investigate  whether  GABAC 
receptor  protein  is  expressed  in  those  areas  of  the  brain  showing  ρ  subunit  mRNA 
expression. The strongest immunoreactivity of all  structures inspected was in the SuC, 
where a prominent density gradient was apparent across its different layers, the highest 
density of ρ subunits being found in the SGL (Fig. 5A,B in  I).  Immunolabelling with 
lower density was also visible within the intermediate and deep layers of the SuC, but the 
distribution of ρ subunits seemed not to follow the map of the visual field representation 
within the SuC.
In addition to SuC, GABAC receptor protein was illustrated in the adult dLGN (Fig. 
5C in I), hippocampus (Fig. 5D-G in I), and MTN, all areas where ρ2 mRNA was detected 
by  in  situ hybridization.  In  the  dLGN,  immunostaining  appeared  to  form layers  with 
mediolateral  orientation.  In  the hippocampus,  staining was restricted to the  CA1 area. 
Immunopositive  puncta  were  to  a  large  extent  restricted  to  the  stratum  pyramidale, 
although some puncta were also visible in the stratum radiatum (Fig. 5E-G in I).
5.2. Characterization of ρ2 homo-oligomeric receptors (II)
5.2.1. ρ2 subunits formed homo-oligomeric GABAC receptors
HEK 293 cells transfected with either ρ1, ρ2, or both ρ1 and ρ2 subunit cDNAs all displayed 
GABA-induced  currents  in  whole-cell  patch-clamp  recordings  (Fig.  1A  in  II).  The 
maximum currents observed in cells expressing homomeric ρ2 receptors were about two 
orders  of  magnitude  smaller  than  in  cells  expressing  homomeric  ρ1 receptors.  Homo-
oligomeric ρ2 receptors also needed at least 3 days to mature after transfection before any 
GABA-induced currents could be detected, while currents with ρ1 receptors were readily 
seen after 24 – 48 h.
This late maturation was confirmed with surface expression studies. FLAG-tagged 
homomeric  ρ2 receptors  appeared  in  the  endoplasmic  reticulum  within  42  h  after 
transfection and the expression peaked at 66 h, decreasing slightly at 90 h (Fig. 2 in II). In 
contrast, the surface expression of ρ2 was seen only at 66 h and increased until 90 h. In 
addition,  the  relatively  weak  surface  expression  of  ρ2 was  strongly  improved  by 
heteromeric  expression  with  either  ρ1 or  ρ3,  while  all  constructs  displayed  similar 
intracellular staining by anti-FLAG antibody under permeabilized conditions (Fig. 3 in II).
5.2.2. Agonist sensitivity of homo-oligomeric ρ2 and hetero-oligomeric ρ1ρ2 receptors
Homomeric ρ2 receptors were more sensitive to GABA than ρ1 receptors, and heteromeric 
receptors ranked between the ρ1 and ρ2 receptors in their sensitivity to GABA (Fig. 1B in 
II). After GABA application, the homomeric ρ2 receptors deactivated more slowly than 
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the  others,  while  the  hetero-oligomeric  ρ1ρ2 receptors  were  the  fastest  in  deactivation 
kinetics.
Furthermore, compared with ρ1 subunit-containing receptors, rat ρ2 homo-oligomeric 
receptors expressed in HEK 293 cells were far more sensitive to CACA, which acted as a 
partial agonist with an EC50 of ≈ 6 μM, the maximum current being 65% of that observed 
with  saturating  GABA  concentration  (Fig.  4  in  II).  The  deactivation  after  CACA 
application was faster than that seen with GABA in all subunits.
5.2.3.  Picrotoxin  sensitivity  of  homo-oligomeric  ρ2 and  hetero-oligomeric  ρ1ρ2 
receptors
The homomeric ρ2 receptors were noticeably less sensitive than ρ1 receptors to PiTX (Fig. 
5A in  II). 100 μM PiTX inhibited only half of the maximum GABA current of the ρ2 
receptors and two-thirds of that of the hetero-oligomeric ρ1ρ2 receptors. Surprisingly, the 
affinity of ρ2 receptors for PiTX was still very high, the IC50 of the picrotoxin-sensitive 
component being only about one-tenth of the IC50 of the ρ1 receptors (Fig. 5B in II).
5.3. GABAC receptors in the rat mature hippocampus (III)
5.3.1. Effects of CACA and TPMPA on excitability
In extracellular recordings from the stratum pyramidale in the hippocampal CA1 area, the 
GABAC receptor agonist CACA potently inhibited stimulus-evoked pEPSP and pSpike 
amplitudes at very low concentrations (Fig. 8). The inhibition of the pSpikes and pEPSPs 
produced  by  CACA  was  reversed  by  the  GABAC receptor  antagonist  TPMPA  in  a 
concentration-dependent manner (Fig. 1B in  III), demonstrating that functional GABAC 
receptors are expressed in the CA1 area. Moreover, CACA was able to reduce multiple, 
epileptiform discharges produced by the GABAA receptor antagonist BIM by one-third, 
showing that the inhibitory effect of CACA was not mediated by GABAA receptors.
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Fig. 8. GABAC receptor activation reduces excitability in the hippocampus.
CACA inhibits pEPSPs and pSpikes at low concentrations.
5.3.2. Effects of CACA on membrane input resistance
In intracellular current-clamp recordings, CACA induced a small but significant decrease 
in the input resistances of neurons calculated from the voltage deflections produced by 
injections of hyperpolarizing current into the cell (Fig. 3A in  III). The CACA-induced 
change in input resistance corresponds to approximately 100 channels/neuron, assuming a 
single-channel conductance of about 10 pS for ρ subunit-containing receptors (Feigenspan 
and Bormann, 1994). Small voltage fluctuations were observed during the experiments, 
which precluded the observation of possible minor potential changes elicited by activated 
GABAC receptors with a reversal potential rather close to the resting membrane potential. 
5.3.3. GDPSP experiments
A  HFS  train  given  in  the  stratum  radiatum in  the  presence  of  ionotropic  glutamate 
receptor blockers results in a biphasic GABA response termed GDPSP or GDNSP (see 
Section  2.3  and  Figure  7  in  Materials  and  methods).  We  hypothesized  that  GABAC 
receptors in the hippocampal CA1 area would be extrasynaptic, possibly activated by the 
spillover of synaptic GABA following this strong stimulation (Isaacson et al., 1993). In a 
total of 17 neurons from different slices, the GDPSP was clearly prolonged by TPMPA, 
indicating that GABAC receptors are activated by synaptically released GABA and that 
they contribute to the attenuation of the depolarizing phase of the GDPSP (Fig. 9A-C). 
During the HFS train, TPMPA affected the hyperpolarizing response within the first 100 
ms (Fig. 9D), but the difference in the voltage between TPMPA and the control grew 
gradually larger over the course of the following 500 ms, suggesting accumulating activity 
of the GABAC receptors.
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Fig. 9. GABAC receptors contribute to depolarizing GABA responses.
(A,B) GDPSPs evoked in the presence of ionotropic  glutamate receptor and GABAB 
receptor  antagonists  are  prolonged  by  50  μM  TPMPA.  (C)  The  original  traces  are 
superimposed. Thin line, control; thicker line, TPMPA. The average effect of TPMPA 
was +16 ± 7.1% (P = 0.04) on time to hIPSP peak, +24 ± 8.0% (P = 0.009) on time to 
GDPSP peak, and + 30 ± 8.0% (P = 0.002) on half-decay of GDPSP. The box indicates 
where the magnification (D) has been taken. (D) A magnification of the first 650 ms of 
the response  to  emphasize  the effects  of  TPMPA on the hyperpolarizing  part  of  the 
response. The difference in the average voltage between TPMPA and control in this cell 
was 1.05 mV within 100 ms starting from the left arrow and 1.69 mV within 100 ms 
starting from the right arrow. Horizontal bars represent the time course of the HFS train. 
Reproduced with permission from Alakuijala  et al.,  2006. © Federation of European 
Neuroscience Societies and Blackwell Publishing Ltd.
With smaller stimulus intensity, insufficient to elicit a GDPSP, no TPMPA effect 
was seen (Fig. 10A,B). As the spillover of the neurotransmitter outside the synaptic cleft 
can be increased either by vigorous stimulation or by preventing the transmitter uptake 
after synaptic release, we further tested the effect of SKF 89976A, a selective blocker of 
GAT-1, which is the major GABA transporter in the hippocampus (Ali et al., 1985). In the 
presence of 10  μM SKF 89976A, we saw a small depolarizing GABA response with a 
stimulus  train  of  five  stimuli  and  –  in  clear  contrast  to  the  observation  made  in  the 
presence  of  GABA  uptake  –  TPMPA  had  a  clear  enhancing  effect  on  the  GDPSP 
amplitude and the GDPSP half-decay (Fig. 10C,D). When GAT-1 was blocked by SKF 
89976A,  the  effect  of  TPMPA was most  prominent  with small  stimulus  intensity  and 
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decreased with increasing stimulus  intensity  to  levels  similar  to  those observed in the 
absence of GAT-1 block (Table 1 in III). This implies that at higher stimulus intensities 
GABAC receptors are already maximally activated by synaptically released GABA, even 
without GABA uptake inhibition. Taken together, our data indicate that GABAC receptors 
in the hippocampal CA1 area are extrasynaptic and activated intrinsically by synaptically 
released GABA via spillover.
Fig.  10. Blocking  GABA  uptake  results  in  GABAC receptor  activation  with  a  few 
stimuli.
(A,B)  When  five  consecutive  stimuli  are  given  at  100  Hz,  only  a  hyperpolarizing 
response is seen in control (A) or in 50 μM TPMPA (B). (C) GAT-1 transporter blocker 
SKF 89976A,  10  μM, increases  the  amount  of  the  transmitter  in  the  vicinity  of  the 
synapse density and a minor depolarizing response is detected. (D) In the presence of 
GAT-1 blocker, TPMPA increases the amplitude and duration of the GDPSP sufficiently 
to introduce spiking. Horizontal bars represent the time course of the HFS train. Note 
that  traces  (A,B)  and (C,D)  are  from separate  experiments,  thus,  traces  (B)  and (C) 
cannot  be  compared.  Reproduced  with  permission  from  Alakuijala  et  al.,  2006.  © 
Federation of European Neuroscience Societies and Blackwell Publishing Ltd.
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6. Discussion
6.1. ρ2 subunits dominate in the postnatal brain
Based on the literature and our results with  in situ hybridization and qRT-PCR, in the 
brain  ρ2 is  the  most  abundant  GABAC receptor  subunit,  present  more  widely  than 
previously  suspected,  but  still  selectively.  Moreover,  GABAC receptor  protein 
immunostaining coincides fully with the expression of ρ2 subunit transcripts.
Similar  expression  levels  of  the  ρ2 subunit  in  the  hippocampus  and  SuC  were 
revealed by qRT-PCR, as expected from the  in situ hybridization. The expression of ρ3 
was in general higher in the hippocampus than in the SuC, while ρ1 was clearly more 
abundant in the SuC. These data imply that the GABAC receptor subunit composition may 
differ  between  these  two  regions.  The  low  levels  of  both  ρ1 and  ρ3 mRNAs  in  the 
hippocampus suggest that adult hippocampal GABAC receptors might predominantly be ρ2 
homo-oligomers.  Of  course,  we  cannot  exclude  the  possibility  of  co-assembly  of  ρ2 
subunits with GABAA receptor subunits, but, hitherto, no evidence supporting ρ2 hetero-
oligomerization  with  other  than  ρ subunits  anywhere  in  the  nervous  system has  been 
presented. In SuC, ρ1 expression levels were similar to ρ2, suggesting a receptor subunit 
composition similar to that in the retina, i.e. ρ1ρ2 hetero-oligomers (Boué-Grabot  et al., 
1998; Greka et al., 2000).
As  for  the  localization  of  the  GABAC receptors  in  the  hippocampus,  we 
demonstrated  that  ρ2 expression  is  restricted  to  the  CA1  area  throughout  postnatal 
development. Our in situ data show that the majority of the somata expresses ρ2 mRNA in 
the CA1 stratum pyramidale (Fig. 8B), where the proportion of inhibitory interneurons is 
estimated to be only about 7% of all neurons (Aika et al., 1994); thus, GABAC receptors 
are putatively localized at least to a major subpopulation of the pyramidal neurons in the 
CA1 area. Our results are in line with some previous reports on the developing and adult 
hippocampus (Boué-Grabot et al., 1998; Wegelius et al., 1998; Ogurusu et al., 1999), but 
in  contrast  to  one  report  showing  the  most  prominent  staining  in  the  interneurons 
throughout the different subfields, although the ρ2 staining was the strongest in the CA1 
area  (Rozzo  et  al.,  2002).  These discrepancies  may be due to the  different  sensitivity 
levels of hybridization probes used in the studies.
The  significance  of  GABAC receptors  outside  the  retina  had  been  questioned 
because even though ρ2 subunits dominate in the rat brain, they did not form functional 
receptors  when expressed alone in  Xenopus oocytes  (Zhang  et  al.,  1995;  2001; Boué-
Grabot  et al.,  1998). The lower temperature used in oocyte  incubation or the different 
intracellular  environment  in  oocytes  compared  with  mammalian  cells  may  somehow 
disturb the maturation of the ρ2 protein or its transport to the cell membrane, as was further 
illustrated with our surface expression studies.  Human and mouse ρ2 homo-oligomeric 
receptors,  on  the  other  hand,  were  functional  in  oocytes,  albeit  the  GABA-induced 
currents in them were small (Kusama et al., 1993b; Greka et al., 1998).
While their expression is challenging, ρ2 subunits carry several unique biophysical 
and pharmacological properties.  Table 4 summarizes the essential pharmacology of the 
three ρ subunits based on the literature and our studies. ρ2 homomeric receptors seem to be 
one of the most sensitive among all GABA receptors to their natural agonist, together with 
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some  α4 or  α6 subunit-containing  extrasynaptic  GABAA receptors.  As  for  CACA,  the 
relatively high affinity of rat  ρ2 receptors implies that at  concentrations below 10  μM, 
CACA activates these receptors highly selectively. This only applies to rat ρ2 receptors, 
though, as human homo-oligomeric ρ2 receptors have a tenfold higher EC50 for CACA 
(Kusama et al., 1993a; Enz and Cutting, 1999).
Table 4. Pharmacological characteristics of individual ρ subunits.
Agonist/antagonist ρ1 subunit ρ2 subunit ρ3 subunit
GABA EC50 (μM) Rat: 1.1–2.3 [1,II],
human: 0.81–1.7 [2,3]
Rat: 0.96 (II),
human: 1.8 [3]
Rat: 4.0–7.5 [4,5]
CACA EC50 (μM) Human: 41–131 [6,7] Rat: 6.3 (II),
human 62–70 [8,7]
Rat: 65–139 [9,5]
TPMPA Kb (μM) Human: 2.3 [10] Human: 14.9 [10] Rat: 4.5 [10]
PiTX IC50 (μM)
+ GABA 10 μM
Rat: 6.7 (II) Rat: 0.60 (II), but only 
partial antagonism
Rat: 3.2 [9]
PiTX IC50 (μM)
+ GABA 20 μM
Rat: 40 [1],
human: 48 [11]
Human: 4.7 [11] Rat: 5.9 [10]
References: [1] Zhang et al., 1995, [2] Chang and Weiss, 1999, [3] Wang et al., 1994, [4] 
Shingai et al., 1996, [5] Vien et al., 2002, [6] Carland et al., 2004, [7] Enz and Cutting, 
1999, [8] Kusama et al., 1993a, [9] Ogurusu et al., 1999, [10] Chebib et al., 2007, [11] 
Wang et al., 1995b
In addition to agonist  sensitivity,  human and rat  ρ2 receptors  differ  also in their 
sensitivity  to  PiTX,  and  in  their  kinetic  properties;  human  ρ2 receptors  are  more 
picrotoxin-sensitive  and  deactivate  faster  than  human  ρ1 receptors  (Enz  and  Cutting, 
1999), while the opposite was seen in rats in our study. Interestingly, the only differences 
in the channel-lining second transmembrane domain between rat and human ρ2 are the 6' 
methionine  and  12'  serine  residues  in  rat,  as  opposed  to  threonine  in  man.  The  only 
differences between rat ρ2 and ρ1 are the 2' serine instead of a proline in ρ1 and the same 6' 
methionine residue, which is, in fact, unique among all GABA receptors (Fig. 11; Cutting 
et al., 1992; Zhang et al., 1995; Korpi et al., 2002). These are the very same amino acid 
residue positions  that  have been demonstrated to affect  picrotoxin  sensitivity  in  many 
substitution studies (Gurley et al., 1995; Wang et al., 1995b; Xu et al., 1995; Zhang et al., 
1995; Zhorov and Bregestovski, 2000). Furthermore, the single-channel conductance of ρ 
receptors has recently been shown to depend on the 2' amino acid residue in the second 
transmembrane domain, as well (Zhu et al., 2007). Identically to mammalian subunits, the 
sequence in the white perch ρ1 subunit contains proline and in the ρ2 subunit serine at the 
2' position. The homo-oligomeric receptors formed by ρ2 subunits gated a channel with a 
16-fold conductance compared with receptors formed by ρ1 subunits, and mutating the 2' 
serine to proline reduced the conductance to a level similar to that of the wild-type ρ1 
receptor (Zhu et al., 2007).
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     Position         2'      6'          12'
ρ1
Rat P A R V P L G I T T V L T M S T I I T G V
Human P A R V P L G I T T V L T M S T I I T G V
 ρ2
Rat P A R V S L G I M T V L T M S T I I T G V
Human P A R V S L G I T T V L T M T T I I T G V
 ρ3 Rat P A R V S L G I T T V L T M S T I V T G V
Fig.  11. Comparison  of  amino  acid  sequences  in  the  channel-lining  second 
transmembrane domain between human and rat ρ subunits. 
The different amino acid residues between rat and human ρ2 subunit and between rat ρ2 
and ρ1 are underlined. The second transmembrane domain in rat and human ρ1 subunits is 
identical. 
In our experiments, no concentration of PiTX could fully block the GABA current 
of  ρ2 subunit-containing  homo-  or  hetero-oligomeric  receptors.  Still,  the  picrotoxin-
sensitive component displayed a very high affinity. This high-affinity partial picrotoxin 
antagonism seems to be unique to rat ρ2 receptors. PiTX has been suggested to interact 
with two binding sites (see Section 2.2.2.2.). The simplest explanation for our findings 
would be that rat ρ2 receptors – with the missing threonine ring at the 6' position in the 
second transmembrane domain – lack the non-competitive binding site to GABA, and 
only the allosteric binding mechanism is left, but acting with a very high affinity. The 
allosteric mechanism deteriorates the efficacy of channel opening, but can never block it 
completely,  thus  resulting  in  partial  antagonism.  In  the  future,  it  would  be  highly 
interesting to determine the characteristics of a mutated ρ2 subunit where the 6' methionine 
has been changed to threonine.
Rat hetero-oligomeric ρ1ρ2 receptors seemed to be relatively close to ρ2 receptors in 
their low and partial sensitivity to PiTX, implying high picrotoxin affinity as a dominant 
trait. Previously, in their study on heteromeric ρ receptors, Zhang and co-workers (1995) 
reported  that  rat  ρ1ρ2 receptors  are  picrotoxin-resistant,  but,  actually,  their  results  are 
equally consistent with a single picrotoxin binding site, as suggested by our data. Because 
homomeric ρ2 receptors were not functional in  Xenopus oocytes, they used ρ1 25% : ρ2 
75% hetero-oligomeric receptors and observed a highly decreased sensitivity to PiTX. A 
simple explanation, in light of our data, is that their results also contain a single, high-
affinity,  low-efficacy PiTX effect,  seen at  very low concentrations of PiTX to already 
affect the GABA response. Mouse ρ2 homo-oligomeric receptors were only tested with 
100 μM PiTX, which blocked 5–22% of the 1 μM GABA response, again in accord with 
our results (Greka et al., 1998).
6.2. Hippocampal GABAC receptors
Our  findings  from  hippocampal  slices  with  conventional  stimulation  indicate  that 
functional GABAC receptors are present in the CA1 area and can be activated by a specific 
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agonist  even  in  bicuculline-mediated  hyperexcited  conditions.  Consistent  with  small 
chloride  conductance  of  GABAC receptor  channels,  the  effect  of  GABAC receptor 
activation was not large; these receptors seem to modulate, rather than block, the overall 
excitability of the pyramidal neurons.
More  impressively,  our  results  from  the  GDPSP  experiments  demonstrate  that 
GABAC receptors  can  be  activated  intrinsically,  either  with  strong  inhibitory  synaptic 
activity or by a weaker stimulus when GABA uptake is blocked. In the absence of GAT-1 
transporter blocker, only strong stimulation could markedly activate GABAC receptors. 
However, when GABA uptake was inhibited, a less vigorous stimulus train was sufficient, 
implying that uptake inhibition increased transmitter spillage to the extrasynaptic areas, 
resulting in the GABAC receptor activation. Our hypothesis about hippocampal GABAC 
receptors being extrasynaptic is also supported by the lack of desensitization and the high 
affinity for GABA of both GABAC receptors and extrasynaptic GABAA receptors (see 
Section 2.1.2.). Furthermore, putatively extrasynaptic GABAC receptors have been found 
in the retina, SuC, and NOT (Schmidt et al., 2001; Ichinose and Lukasiewicz, 2002; Boller 
and  Schmidt,  2003;  Kirischuk  et  al.,  2003).  Figure  12  is  a  schematic  illustration  of 
synaptic GABA spillover.
Fig. 12. Schematic of the concept of GABA spillover.
According to our hypothesis, GABAC receptors in the hippocampal pyramidal cells are 
extrasynaptic  and  activated  by  the  spillage  of  GABA  outside  the  synaptic  clefts 
following  HFS  or  when  GABA  uptake  is  blocked.  In  addition,  GABAC receptor 
activation can be heterosynaptic, i.e. transmitter spilled over from synapses in adjacent 
neurons can sometimes activate sensitive GABAC receptors.
Previously,  extrasynaptic  GABAA receptors  have  been  demonstrated  to  mediate 
tonic currents in interneurons and pyramidal cells in the hippocampus (Semyanov et al., 
2003; Yeung  et al., 2003; Caraiscos  et al., 2004). Also in our experiments, rapid initial 
hyperpolarization was enhanced by GAT-1 blocker, and this enhancement was TPMPA-
insensitive,  supporting  the  idea  of  GABAA receptor  activation  by  spillover.  Thus,  in 
experiments  like  ours,  the  vigorous  stimulation  leading  to  spillover  of  GABA  to 
extrasynaptic membranes may also activate putative extrasynaptic GABAA and GABAB 
receptors.  However,  in  our  study,  the  contribution  of  GABAC receptors  was 
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pharmacologically isolated with the presence of the GABAB antagonist CGP 46381 and 
confirmed by using small concentrations of TPMPA (see Section 2.2.2.2.).
Our  results  from  GDPSP  experiments  support  the  theory  of  the  mechanism  of 
biphasic  GABA-mediated  responses  being  a  bicarbonate-  and  carbonic  anhydrase-
dependent  transmission,  non-synaptic  in  nature  (see  Section  2.3.).  Inhibitory  GABAC 
receptors in the pyramidal neuron, from which the measurement is made, do not sensitize, 
and thus, the effect of TPMPA is more prominent towards the end of the late depolarizing 
phase of the GDPSP, when GABAA receptors are desensitized. Hence, the smaller GABAC 
receptor conductance is more apparent in the voltage recording, inhibiting slightly but 
clearly the long-lasting depolarization of the pyramidal neuron. An alternative explanation 
might be that TPMPA inhibits putative GABAC receptors in interneurons and has an effect 
on their GABA release, but we find this explanation unlikely, as our immunostainings did 
not reveal a location of GABAC receptors in interneurons (but see Rozzo et al., 2002). 
Since  our  results  are  consistent  with  the  known  pharmacological  properties  of 
GABAC receptors,  receptors  comprising  exclusively  ρ  subunits  apparently  exist  in  the 
adult  hippocampal  pyramidal  cells,  as  well  as  in  retinal  bipolar  cells  and  collicular 
interneurons  in  the  SGL.  By  contrast,  a  mixed  GABAA/GABAC receptor  population 
possibly is present in hippocampal interneurons, juvenile hippocampal pyramidal cells, 
cerebellar Purkinje cells, lamina II neurons in the spinal cord, brainstem DVN neurons and 
the amygdala (see Section 2.2.5.).
6.3. Visual system specificity
The  highly  specific  expression  of  ρ2 subunits  in  brain  regions  related  to  vision  is 
noteworthy. In addition to the retina, expression of ρ2 mRNA and ρ protein are seen in the 
SGL of the SuC, the NOT, the MTN of the accessory optic tract, the dLGN, and the visual 
cortex.  These  nuclei  are  retinorecipient,  i.e.  receive  direct  input  from  directionally 
selective retinal ganglion cells and are heavily interconnected by GABAergic connections 
(Van der Want et al., 1992). Moreover, they all analyse information about the motion of 
single visual objects or the entire visual image. Based on our findings and previous results 
demonstrating GABAC receptors at transcript, protein and functional levels in the nuclei of 
visual pathways, GABAC receptors may be assumed to be specifically involved in aspects 
of  visual  image  motion  processing  in  the  rat  brain.  The  hippocampus  as  a  base  for 
visuospatial memory fits well with this assumption.
In  the  SGL  of  the  SuC,  GABAC receptors  are  preferentially,  or  exclusively, 
expressed by local GABAergic interneurons. Similarly, in dLGN, GABAC receptors have 
been  detected  in  GABAergic  interneurons.  In  SGL,  inhibitory  interneurons  comprise 
about half of the neuron population, and a similar proportion of cells expresses ρ2 mRNA. 
Consistently, the function of GABAC receptors is disinhibitory in the SuC, as well as in 
dLGN,  as  reflected  by  the  preferential  expression  of  GABAC receptors  by  local 
GABAergic interneurons.
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6.4. Nomenclature of GABA receptors
Whether  there  actually  are  “GABAC receptors”  or  “GABAA receptors  consisting  of  ρ 
subunits”  in  the  nervous  system  has  been  a  subject  of  discussion  ever  since  their 
discovery.  Arguments  corroborating  the  separate  groups  of  A  and C  comprise  strong 
pharmacological differences: GABAC receptors are insensitive to bicuculline, barbiturates 
and benzodiazepines,  have specific agonists  and antagonists,  and are more sensitive to 
GABA than  classical  GABAA receptors.  In  addition,  GABAC receptors  display  a  low 
single-channel conductance, activate and deactivate more slowly and do not desensitize. In 
most  of  these  respects,  GABAC receptors  do,  however,  more  strongly  resemble  the 
recently discovered extrasynaptic GABAA receptors. As a matter of fact, both GABAA and 
GABAC receptors  are  heterogeneous  groups  of  different  subtypes  with  distinctive 
pharmacology,  subcellular  localization  and  function.  As  concluded  in  this  work,  one 
cannot  briefly  describe  a  typical  GABAC receptor  any  better  than  a  typical  GABAA 
receptor.
Based on amino acid  sequences,  ρ receptors  are  considered phylogenetically  old 
GABA receptors, together with β, δ, θ, and π subunits (Whiting et al., 1999). As for the 
phylogenetically oldest, invertebrate GABA receptors, they do not fit into these vertebrate 
receptor categories, because, for example, crustacean ionotropic GABA receptors share 
pharmacological  properties  of  both  GABAA and  GABAC receptors  (Takeuchi  and 
Onodera, 1972; Jackel et al., 1994; Wegelius, 2000). It is noteworthy that the genes for 
GABAA and  GABAC receptors  are  differentially  localized  within  the  genome,  thus 
promoting the distinction. Four chromosomes (4, 5, 15 and X) in the human genome each 
contain a cluster of genes for α, β and γ subunits in a stoichiometry that accounts for most 
of the native GABAA receptors. In contrast, the genes for ρ subunits lie on chromosomes 3 
and 6 (Bormann, 2000).
While findings of distinct intracellular anchoring proteins for GABAA and GABAC 
receptors support the separation, recent evidence for the possibility of co-assembly of ρ 
and γ subunits strongly disagree with it. Not only fish but also rat ρ1 subunit was shown to 
be  associated  with  GABAA receptor  subunits  in  brainstem  and  cerebellar  lysates. 
Moreover, several confusing results about native receptors with mixed pharmacological 
properties of both GABAA and GABAC receptors cannot be explained by such a close 
localization of both receptor types that one could find a GABAA receptor and a GABAC 
receptor on the same patch, as suggested by Hartmann and co-workers (2004).
Still, if one considered the concept of GABAC receptors equivocal in light of the 
recent  data,  what  could  be  proposed  in  its  place?  An  IUPHAR  committee  has 
recommended  the  use  of  the  term GABAA0r to  describe  bicuculline-insensitive  retinal 
receptors  and,  for  example,  GABAA0r12 for  ρ1ρ2 hetero-oligomeric  GABAC receptors 
(Barnard  et  al.,  1998),  but  no  authors  have  used  this  clumsy  nomenclature  in  any 
publication. In fact, despite these recommendations, no change in the nomenclature of any 
GABA  receptor  subtypes  has  been  seen.  As  long  as  the  subunit  composition  of  the 
different types  of native GABA receptors  is  unknown, it  would perhaps be simpler to 
continue with the already established nomenclature instead of introducing a new, possibly 
inadequate system.
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7. Conclusions
Evidence of functional putatively homo-oligomeric hippocampal GABAC receptors is the 
key finding in this thesis.  As GABAC receptors  are  most abundantly  expressed in the 
retina and SuC, these areas have received major attention in GABAC receptor studies, and 
the  prevalence  of  GABAC receptors  outside  these  structures  has  been  more  or  less 
questioned. Our results demonstrate that, among many other receptor types, the  stratum 
pyramidale in the CA1 area of the hippocampus possess functional GABAC receptors that 
contribute to endogenous GABA responses.
During the past decade or so, the concept of tonic inhibition has become an essential 
part of network functions, side by side with phasic, conventional inhibition. Tonic and 
spillover  inhibition  mediated  by  receptors  outside  synaptic  sites  modulate  the  overall 
excitability of nerve cells in a way that can increase the information storage capability, 
while sheltering from excessive excitation. GABAC receptors are characterized by their 
lack  of  desensitization  and  their  high  agonist  affinity;  as  such,  they  represent  ideal 
candidates for the mediation of tonic or spillover inhibition. The first evidence supporting 
their role in spillover inhibition has been revealed in the hippocampus by our group, and 
in the retina, SuC and NOT by others, while their contribution to tonic inhibition has not 
yet been shown. GABAC receptors are, by no means, exclusively extrasynaptic, however, 
their localization in synapses and their contribution to synaptic transmission have been 
thoroughly  established  in  retinal  bipolar  cells.  All  in  all,  GABAC receptors  seem  to 
compose a surprisingly heterogeneous group of receptors when taking into consideration 
pharmacological  characteristics  and subcellular  localization,  as  well  as their  functional 
role in the nervous system, as shown partly in this work and in the review of the literature.
The  contribution  of  the  ρ2 subunit  to  GABACergic  transmission  in  the  central 
nervous system is, undoubtedly, the second main finding in this study. ρ2 subunits were 
demonstrated  to  dominate  in  both  the  hippocampus  and  SuC  during  postnatal 
development,  and the  expression  of  ρ2 also  coincided  fully  with  the  GABAC receptor 
protein, as illustrated by immunocytochemistry. Our results display, for the first time, the 
functionality of the rat ρ2 homo-oligomeric GABAC receptors. Taken together with the 
unique  pharmacological  and  biophysical  characteristics  of  the  ρ2 homo-oligomeric 
receptors detected, many previous questions concerning native GABAC receptors appear 
to  have  found  their  answers,  one  example  being  the  picrotoxin  resistance  of  retinal 
GABAC receptors.
The low levels of both ρ1 and ρ3 mRNAs in the hippocampus, combined with our 
results of the distinctive pharmacology of ρ2 receptors expressed in HEK 293 cells and the 
pharmacology  demonstrated  in  hippocampal  slices,  suggest  that  adult  hippocampal 
GABAC receptors might predominantly be ρ2 homo-oligomers. Because the currents of the 
homo-oligomeric ρ2 receptors were small and their maturation slow but strongly improved 
by heteromeric expression, possibly the role of the ρ2 subunits is to combine with some 
other  subunits  and modulate  their  properties.  In  some parts of  the nervous system,  ρ1 
subunits seem to co-assemble with ρ2 subunits, and in other parts putatively with GABAA 
receptor subunits. Similarly, ρ2 subunits may profit from an as yet unknown subunit for 
efficient  functionality  as  a  part  of  an  inhibitory  network.  Whichever  is  the  case,  ρ2 
subunits can no longer be overlooked when either the function of the hippocampus or the 
GABAC receptors anywhere in the nervous system is studied.
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